1	The	DT	O	the	det	4	SENT_1	[p1l713t81r750b103],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l762t83r843b103],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l857t83r1032b103],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l1046t83r1212b110],
5	£	CD	NUMBER	£	num	4	SENT_1	[p1l1226t81r1442b109],
6	y	JJ	O	y	dep	4	SENT_1	[p1l1226t81r1442b109],
7	"	``	O	"	punct	6	SENT_1	[p1l1226t81r1442b109],
8	MEDICINE	NNP	O	MEDICINE	dep	6	SENT_1	[p1l1226t81r1442b109],

1	by	IN	O	by	_	0	SENT_2	[p1l236t185r274b224],
2	Schnyder	NNP	PERSON	Schnyder	prep_by	7	SENT_2	[p1l283t185r434b224],
3	et	FW	O	et	nn	4	SENT_2	[p1l443t192r472b216],
4	al.	FW	O	al.	dep	2	SENT_2	[p1l480t185r516b216],
5	did	VBD	O	do	aux	7	SENT_2	[p1l528t185r580b216],
6	not	RB	O	not	neg	7	SENT_2	[p1l589t192r645b216],
7	include	VB	O	include	_	0	SENT_2	[p1l653t185r773b216],
8	subjects	NNS	O	subject	nsubj	13	SENT_2	[p1l783t185r913b225],
9	with	IN	O	with	_	0	SENT_2	[p1l922t185r995b216],
10	ho	NN	O	ho	nn	12	SENT_2	[p1l1005t185r1059b216],
11	—	NN	O	—	nn	12	SENT_2	[p1l1005t185r1059b216],
12	H	NN	O	h	prep_with	8	SENT_2	[p1l1102t187r1125b215],
13	arry	JJ	O	arry	xcomp	7	SENT_2	[p1l1132t196r1194b226],
14	Su	FW	MISC	su	nn	15	SENT_2	[p1l1207t187r1246b216],
15	ryapranata	FW	O	ryapranata	nsubj	7	SENT_2	[p1l1253t191r1439b226],
16	,	,	O	,	_	0	SENT_2	[p1l1253t191r1439b226],
17	M	NN	O	m	appos	15	SENT_2	[p1l1456t187r1484b215],
18	.	.	O	.	_	0	SENT_2	[p1l1491t211r1496b216],

1	D.	NNP	O	D.	nn	3	SENT_3	[p1l1503t187r1536b216],
2	mocysteine	NN	O	mocysteine	nn	3	SENT_3	[p1l236t236r421b274],
3	levels	NNS	O	level	_	0	SENT_3	[p1l433t235r522b266],
4	higher	JJR	O	higher	dep	3	SENT_3	[p1l535t235r644b274],
5	than	IN	O	than	_	0	SENT_3	[p1l655t235r729b266],
6	13.5	CD	NUMBER	13.5	num	7	SENT_3	[p1l743t237r811b266],
7	pmol	NN	O	pmol	prep_than	4	SENT_3	[p1l826t235r908b274],
8	per	IN	O	per	_	0	SENT_3	[p1l920t245r974b274],
9	liter	NN	O	liter	prep_per	7	SENT_3	[p1l986t235r1058b266],
10	.	.	O	.	_	0	SENT_3	[p1l986t235r1058b266],

1	Isala	NNP	O	Isala	nn	3	SENT_4	[p1l1101t243r1157b267],
2	Klinieken	NNP	O	Klinieken	nn	3	SENT_4	[p1l1169t243r1282b267],
3	Studies	NNS	O	study	nsubjpass	5	SENT_4	[p1l237t284r354b315],
4	are	VBP	O	be	auxpass	5	SENT_4	[p1l366t294r415b315],
5	needed	VBN	O	need	_	0	SENT_4	[p1l426t284r543b315],
6	that	WDT	O	that	nsubj	8	SENT_4	[p1l554t284r619b315],
7	will	MD	O	will	aux	8	SENT_4	[p1l626t284r687b315],
8	test	VB	O	test	ccomp	5	SENT_4	[p1l698t291r757b315],
9	the	DT	O	the	det	10	SENT_4	[p1l767t284r817b315],
10	eﬂicacy	NN	O	eﬂicacy	dobj	8	SENT_4	[p1l828t284r952b324],
11	of	IN	O	of	_	0	SENT_4	[p1l962t284r1001b315],
12	ho	NN	O	ho	prep_of	10	SENT_4	[p1l1005t284r1059b315],
13	—	CD	NUMBER	—	number	14	SENT_4	[p1l1005t284r1059b315],
14	3	CD	NUMBER	3	num	16	SENT_4	[p1l1099t281r1196b310],
15	°	NN	O	°	nn	16	SENT_4	[p1l1099t281r1196b310],
16	11JW	NN	O	11jw	dep	12	SENT_4	[p1l1099t281r1196b310],
17	ZW	NN	O	zw	dep	16	SENT_4	[p1l1205t280r1293b308],
18	°	CD	NUMBER	°	num	17	SENT_4	[p1l1205t280r1293b308],
19	"	``	O	"	punct	20	SENT_4	[p1l1205t280r1293b308],
20	ev	VB	O	ev	dep	10	SENT_4	[p1l1205t280r1293b308],
21	the	DT	O	the	det	22	SENT_4	[p1l1303t280r1343b304],
22	N	NN	O	n	dobj	20	SENT_4	[p1l1354t280r1510b304],
23	°	CD	NUMBER	°	number	24	SENT_4	[p1l1354t280r1510b304],
24	*	CD	NUMBER	*	num	25	SENT_4	[p1l1354t280r1510b304],
25	“	NN	O	“	dep	22	SENT_4	[p1l1354t280r1510b304],
26	e	SYM	O	e	dep	22	SENT_4	[p1l1354t280r1510b304],
27	"	``	O	"	punct	8	SENT_4	[p1l1354t280r1510b304],
28	a	DT	O	a	det	30	SENT_4	[p1l1354t280r1510b304],
29	“	NN	O	“	nn	30	SENT_4	[p1l1354t280r1510b304],
30	d5	NN	O	d5	dobj	8	SENT_4	[p1l1354t280r1510b304],
31	. . . . .	CD	NUMBER	. . . . .	num	30	SENT_4	[p1l777t335r782b340],[p1l374t335r379b340],
32	.	.	O	.	_	0	SENT_4	[p1l977t335r982b340],

1	.	.	O	.	_	0	SENT_5	[p1l1010t335r1015b340],

1	hsuryapranata@diagram-zwo	NN	O	hsuryapranata@diagram-zwo	_	0	SENT_6	[p1l1100t318r1541b349],
2	|	CD	NUMBER	|	number	3	SENT_6	[p1l1100t318r1541b349],
3	|	CD	NUMBER	|	num	5	SENT_6	[p1l1100t318r1541b349],
4	e.	NN	O	e.	nn	5	SENT_6	[p1l1100t318r1541b349],
5	n	NN	O	n	dep	1	SENT_6	[p1l1100t318r1541b349],
6	|	IN	O	|	amod	5	SENT_6	[p1l1100t318r1541b349],

1	I1	NN	O	i1	nsubj	6	SENT_7	[p1l236t335r582b374],
2	’	CD	NUMBER	’	num	1	SENT_7	[p1l236t335r582b374],
3	1OCySt	NN	O	1ocyst	nn	6	SENT_7	[p1l236t335r582b374],
4	€	CD	NUMBER	€	num	6	SENT_7	[p1l236t335r582b374],
5	ll	NN	O	ll	nn	6	SENT_7	[p1l236t335r582b374],
6	’	NN	O	’	_	0	SENT_7	[p1l236t335r582b374],
7	1	CD	MONEY	1	dep	6	SENT_7	[p1l236t335r582b374],
8	€	SYM	MONEY	€	dep	6	SENT_7	[p1l236t335r582b374],
9	-	:	O	-	_	0	SENT_7	[p1l236t335r582b374],
10	lOW	NN	O	low	nn	12	SENT_7	[p1l236t335r582b374],
11	€	CD	NUMBER	€	num	12	SENT_7	[p1l236t335r582b374],
12	lflI1g	NN	O	lfli1g	dep	27	SENT_7	[p1l236t335r582b374],
13	Vltal	JJ	O	vltal	amod	15	SENT_7	[p1l587t341r713b366],
14	’	NN	O	’	nn	15	SENT_7	[p1l587t341r713b366],
15	l’llI1	NN	O	l’lli1	dep	12	SENT_7	[p1l587t341r713b366],
16	1	CD	MONEY	1	number	17	SENT_7	[p1l721t345r873b374],
17	‘	CD	MONEY	‘	num	22	SENT_7	[p1l721t345r873b374],
18	€	NN	MONEY	€	nn	22	SENT_7	[p1l721t345r873b374],
19	glII16l	NN	O	glii16l	nn	22	SENT_7	[p1l721t345r873b374],
20	’	CD	NUMBER	’	num	22	SENT_7	[p1l721t345r873b374],
21	1S	NN	O	1	nn	22	SENT_7	[p1l721t345r873b374],
22	COl	NN	O	col	dep	12	SENT_7	[p1l882t341r1061b374],
23	’	CD	NUMBER	’	num	25	SENT_7	[p1l882t341r1061b374],
24	1talI1lI1g	NN	O	1tali1li1g	nn	25	SENT_7	[p1l882t341r1061b374],
25	betaine	NN	O	betaine	dep	22	SENT_7	[p1l236t385r356b416],
26	instead	RB	O	instead	advmod	27	SENT_7	[p1l365t385r483b416],
27	offolate	JJ	O	offolate	parataxis	6	SENT_7	[p1l493t385r635b416],
28	.	.	O	.	_	0	SENT_7	[p1l493t385r635b416],

1	1	LS	NUMBER	1	_	0	SENT_8	[p1l1099t396r1118b416],
2	.	.	O	.	_	0	SENT_8	[p1l1099t396r1118b416],

1	Schnyder	NNP	O	Schnyder	nn	2	SENT_9	[p1l1149t393r1263b422],
2	G	NNP	O	G	_	0	SENT_9	[p1l1269t395r1297b421],
3	,	,	O	,	_	0	SENT_9	[p1l1269t395r1297b421],
4	Roi-H	NN	O	roi-h	nn	5	SENT_9	[p1l1305t393r1367b417],
5	M	NN	O	m	appos	2	SENT_9	[p1l1373t395r1404b420],
6	,	,	O	,	_	0	SENT_9	[p1l1373t395r1404b420],
7	Pin	NN	O	pin	nn	8	SENT_9	[p1l1413t393r1452b415],
8	R	NN	O	r	appos	2	SENT_9	[p1l1459t395r1484b421],
9	,	,	O	,	_	0	SENT_9	[p1l1459t395r1484b421],
10	et	FW	O	et	nn	11	SENT_9	[p1l1493t398r1516b416],
11	al.	FW	O	al.	appos	2	SENT_9	[p1l1521t393r1549b416],
12	.	.	O	.	_	0	SENT_9	[p1l1521t393r1549b416],

1	Decreased	VBN	O	decrease	_	0	SENT_10	[p1l1557t393r1684b416],
2	rate	NN	O	rate	dobj	1	SENT_10	[p1l1691t398r1736b416],
3	of	IN	O	of	_	0	SENT_10	[p1l1744t393r1773b416],
4	corona	NN	O	corona	nn	5	SENT_10	[p1l1775t400r1860b416],
5	restenosis	NN	O	restenosis	prep_of	2	SENT_10	[p1l1890t400r1923b416, p1l1099t431r1198b453],
6	after	IN	O	after	_	0	SENT_10	[p1l1204t430r1261b453],
7	lowering	VBG	O	lower	prepc_after	1	SENT_10	[p1l1266t430r1376b460],
8	of	IN	O	of	_	0	SENT_10	[p1l1382t430r1411b453],
9	plasma	NN	O	plasma	nn	11	SENT_10	[p1l1412t430r1501b460],
10	homocysteine	NN	O	homocysteine	nn	11	SENT_10	[p1l1507t430r1678b460],
11	levels	NNS	O	level	prep_of	7	SENT_10	[p1l1684t430r1758b454],
12	.	.	O	.	_	0	SENT_10	[p1l1684t430r1758b454],

1	N	NN	O	n	nn	2	SENT_11	[p1l1766t432r1787b454],
2	En	NN	O	en	nsubj	3	SENT_11	[p1l1793t432r1826b453],
3	ed	VBD	O	ed	_	0	SENT_11	[p1l1895t430r1923b454],

1	Helmut	NNP	PERSON	Helmut	poss	5	SENT_12	[p1l239t447r366b478],
2	'	POS	O	'	_	0	SENT_12	[p1l381t450r488b488],
3	-	:	O	-	_	0	SENT_12	[p1l381t450r488b488],
4	ailgev	NN	O	ailgev	nn	5	SENT_12	[p1l381t450r488b488],
5	M-D	NN	O	m-d	_	0	SENT_12	[p1l505t450r585b478],
6	-	:	O	-	_	0	SENT_12	[p1l505t450r585b478],
7	2001	CD	DATE	2001	dep	5	SENT_12	[p1l1099t470r1347b491],
8	~	CD	NUMBER	~	number	9	SENT_12	[p1l1099t470r1347b491],
9	345:1593	CD	NUMBER	345:1593	dep	7	SENT_12	[p1l1099t470r1347b491],
10	—	NN	O	—	dep	9	SENT_12	[p1l1099t470r1347b491],
11	600	CD	NUMBER	600	num	10	SENT_12	[p1l1099t470r1347b491],
12	.	.	O	.	_	0	SENT_12	[p1l1099t470r1347b491],

1	Klinikum	NNP	O	Klinikum	nn	4	SENT_13	[p1l238t507r348b531],
2	Links	NNP	O	Links	nn	4	SENT_13	[p1l361t507r424b531],
3	der	FW	O	der	nn	4	SENT_13	[p1l434t507r475b531],
4	Weser	NNP	O	Weser	_	0	SENT_13	[p1l483t509r561b531],
5	2	CD	NUMBER	2	dep	4	SENT_13	[p1l1098t509r1118b530],
6	.	.	O	.	_	0	SENT_13	[p1l1098t509r1118b530],

1	Herrmann	NNP	PERSON	Herrmann	nn	2	SENT_14	[p1l1148t508r1277b530],
2	HC	NNP	O	HC	_	0	SENT_14	[p1l1285t508r1332b530],
3	.	.	O	.	_	0	SENT_14	[p1l1285t508r1332b530],

1	Prevention	NNP	O	Prevention	_	0	SENT_15	[p1l1341t507r1473b530],
2	of	IN	O	of	_	0	SENT_15	[p1l1481t506r1510b530],
3	cardiovascu	NN	O	cardiovascu	prep_of	1	SENT_15	[p1l1513t506r1657b530],
4	at	IN	O	at	_	0	SENT_15	[p1l1666t514r1690b530],
5	events	NNS	O	event	prep_at	1	SENT_15	[p1l1698t511r1773b530],
6	after	IN	O	after	_	0	SENT_15	[p1l1781t506r1838b530],
7	percu28355	NN	O	percu28355	nn	10	SENT_15	[p1l1844t514r1923b536, p1l236t541r311b563],
8	B	NN	O	b	nn	10	SENT_15	[p1l323t541r337b563],
9	eeee	NN	O	eeee	nn	10	SENT_15	[p1l341t548r404b563],
10	n	NN	O	n	prep_after	5	SENT_15	[p1l408t548r428b567],
11	,	,	O	,	_	0	SENT_15	[p1l408t548r428b567],
12	Germany	NNP	LOCATION	Germany	nn	15	SENT_15	[p1l439t541r556b570],
13	taneous	JJ	O	taneous	amod	15	SENT_15	[p1l1099t544r1195b562],
14	coronary	JJ	O	coronary	amod	15	SENT_15	[p1l1203t546r1312b568],
15	intervention	NN	O	intervention	appos	10	SENT_15	[p1l1318t539r1474b562],
16	.	.	O	.	_	0	SENT_15	[p1l1318t539r1474b562],

1	N	NN	O	n	nn	2	SENT_16	[p1l1482t541r1504b562],
2	EnglJMe	NN	O	engljme	_	0	SENT_16	[p1l1510t539r1626b568],
3	04	CD	NUMBER	04	num	5	SENT_16	[p1l1680t541r1875b566],
4	;	:	O	;	_	0	SENT_16	[p1l1680t541r1875b566],
5	350:2708	CD	NUMBER	350:2708	dep	2	SENT_16	[p1l1680t541r1875b566],
6	—	CD	NUMBER	—	number	7	SENT_16	[p1l1680t541r1875b566],
7	10	CD	NUMBER	10	dep	5	SENT_16	[p1l1680t541r1875b566],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_17	[p1l503t649r652b694],
2	Mutations	NNS	O	mutation	_	0	SENT_17	[p1l672t647r940b694],
3	and	CC	O	and	_	0	SENT_17	[p1l959t646r1053b694],
4	Sensitivity	NN	O	sensitivity	conj_and	2	SENT_17	[p1l1074t647r1347b709],
5	to	TO	O	to	_	0	SENT_17	[p1l1362t654r1414b694],
6	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	2	SENT_17	[p1l1432t645r1660b694],

1	TO	TO	O	to	aux	3	SENT_18	[p1l8t871r109b920],
2	THE	DT	O	the	det	3	SENT_18	[p1l136t871r287b919],
3	EDITOR	NN	O	editor	_	0	SENT_18	[p1l322t871r625b920],
4	:	:	O	:	_	0	SENT_18	[p1l322t871r625b920],
5	The	DT	O	the	det	7	SENT_18	[p1l651t843r813b920],
6	important	JJ	O	important	amod	7	SENT_18	[p1l853t844r1287b942],
7	study	NN	O	study	dep	3	SENT_18	[p1l1323t843r1548b942],
8	by	IN	O	by	_	0	SENT_18	[p1l1584t843r1681b942],
9	Dr.	NNP	O	Dr.	nn	10	SENT_18	[p1l1714t849r1840b921],
10	Lynch	NNP	PERSON	Lynch	prep_by	3	SENT_18	[p1l1883t843r2136b942],
11	and	CC	O	and	_	0	SENT_18	[p1l9t971r164b1050],
12	colleagues	NNS	O	colleague	prep_by	3	SENT_18	[p1l185t971r620b1072],
13	(	CD	NUMBER	(	num	14	SENT_18	[p1l648t978r853b1071],
14	May	NNP	DATE	May	tmod	19	SENT_18	[p1l648t978r853b1071],
15	20	CD	DATE	20	num	17	SENT_18	[p1l869t977r969b1050],
16	issue	NN	O	issue	nn	17	SENT_18	[p1l990t972r1274b1062],
17	)	NN	O	)	nsubj	19	SENT_18	[p1l990t972r1274b1062],
18	1	CD	NUMBER	1	dep	17	SENT_18	[p1l990t972r1274b1062],
19	suggests	VBZ	O	suggest	rcmod	12	SENT_18	[p1l1296t988r1655b1072],
20	that	IN	O	that	complm	32	SENT_18	[p1l1678t971r1843b1049],
21	specific	JJ	O	specific	amod	22	SENT_18	[p1l1860t970r2135b1071, p1l9t1100r78b1177],
22	mutations	NNS	O	mutation	nsubj	32	SENT_18	[p1l104t1100r534b1178],
23	in	IN	O	in	_	0	SENT_18	[p1l562t1100r644b1176],
24	the	DT	O	the	det	28	SENT_18	[p1l670t1099r799b1177],
25	epidermal	JJ	O	epidermal	amod	28	SENT_18	[p1l827t1099r1252b1199],
26	growth	NN	O	growth	nn	28	SENT_18	[p1l1278t1099r1580b1200],
27	factor	NN	O	factor	nn	28	SENT_18	[p1l1607t1098r1853b1178],
28	receptor	NN	O	receptor	prep_in	22	SENT_18	[p1l1877t1125r2135b1199, p1l11t1244r131b1306],
29	(	CD	NUMBER	(	num	30	SENT_18	[p1l161t1233r467b1318],
30	EGFR	NN	ORGANIZATION	egfr	dep	28	SENT_18	[p1l161t1233r467b1318],
31	)	CD	NUMBER	)	dep	30	SENT_18	[p1l161t1233r467b1318],
32	characterize	VBP	O	characterize	ccomp	19	SENT_18	[p1l500t1227r1010b1305],
33	a	DT	O	a	det	34	SENT_18	[p1l1037t1253r1082b1305],
34	subgroup	NN	O	subgroup	dobj	32	SENT_18	[p1l1109t1227r1512b1328],
35	of	IN	O	of	_	0	SENT_18	[p1l1541t1226r1642b1306],
36	non	JJ	O	non	amod	40	SENT_18	[p1l1651t1227r2135b1306, p1l11t1355r152b1433],
37	—	NN	O	—	nn	40	SENT_18	[p1l1651t1227r2135b1306, p1l11t1355r152b1433],
38	smallcell	NN	O	smallcell	nn	40	SENT_18	[p1l1651t1227r2135b1306, p1l11t1355r152b1433],
39	lung	NN	O	lung	nn	40	SENT_18	[p1l182t1355r377b1456],
40	cancers	NNS	O	cancer	prep_of	34	SENT_18	[p1l406t1381r719b1433],
41	that	WDT	O	that	nsubj	45	SENT_18	[p1l753t1355r920b1433],
42	may	MD	O	may	aux	45	SENT_18	[p1l947t1381r1124b1455],
43	be	VB	O	be	cop	45	SENT_18	[p1l1151t1355r1247b1434],
44	highly	RB	O	highly	advmod	45	SENT_18	[p1l1279t1355r1546b1456],
45	responsive	JJ	O	responsive	rcmod	40	SENT_18	[p1l1573t1356r2024b1455],
46	to	TO	O	to	_	0	SENT_18	[p1l2056t1372r2135b1434],
47	geﬁtinib	NN	O	geﬁtinib	nn	48	SENT_18	[p1l10t1482r374b1584],
48	therapy	NN	O	therapy	prep_to	45	SENT_18	[p1l423t1483r759b1583],
49	.	.	O	.	_	0	SENT_18	[p1l423t1483r759b1583],

1	Do	VB	O	do	_	0	SENT_19	[p1l811t1490r934b1562],
2	these	DT	O	these	det	3	SENT_19	[p1l984t1483r1207b1561],
3	mutations	NNS	O	mutation	nsubj	4	SENT_19	[p1l1256t1484r1695b1562],
4	predict	VBP	O	predict	ccomp	1	SENT_19	[p1l1744t1483r2050b1583],
5	a	DT	O	a	det	7	SENT_19	[p1l2092t1509r2137b1561],
6	greater	JJR	O	greater	amod	7	SENT_19	[p1l10t1628r307b1712],
7	sensitivity	NN	O	sensitivity	dobj	4	SENT_19	[p1l352t1613r772b1711],
8	to	TO	O	to	_	0	SENT_19	[p1l814t1628r893b1690],
9	chemotherapy	NN	O	chemotherapy	prep_to	4	SENT_19	[p1l942t1611r1549b1711],
10	as	RB	O	as	advmod	11	SENT_19	[p1l1590t1637r1674b1689],
11	well	RB	O	well	advmod	4	SENT_19	[p1l1718t1609r1931b1690],
12	?	.	O	?	_	0	SENT_19	[p1l1718t1609r1931b1690],

1	The	DT	O	the	det	5	SENT_20	[p1l1975t1611r2137b1689],
2	overall	JJ	O	overall	amod	5	SENT_20	[p1l11t1739r289b1818],
3	objective	JJ	O	objective	amod	5	SENT_20	[p1l323t1739r690b1839],
4	response	NN	O	response	nn	5	SENT_20	[p1l724t1765r1103b1839],
5	rate	NN	O	rate	nsubj	21	SENT_20	[p1l1137t1756r1293b1817],
6	to	TO	O	to	aux	7	SENT_20	[p1l1328t1756r1407b1818],
7	ﬂrst	VB	O	ﬂrst	infmod	5	SENT_20	[p1l1442t1738r1803b1817],
8	—	CD	NUMBER	—	num	11	SENT_20	[p1l1442t1738r1803b1817],
9	line	NN	O	line	nn	11	SENT_20	[p1l1442t1738r1803b1817],
10	combination	NN	O	combination	nn	11	SENT_20	[p1l1838t1739r2135b1818, p1l10t1868r278b1946],
11	chemotherapy	NN	O	chemotherapy	dobj	7	SENT_20	[p1l300t1867r902b1967],
12	for	IN	O	for	_	0	SENT_20	[p1l918t1866r1040b1946],
13	metastatic	JJ	O	metastatic	amod	15	SENT_20	[p1l1058t1868r1492b1945],
14	non	JJ	O	non	amod	15	SENT_20	[p1l1512t1867r2138b1946],
15	—	NN	O	—	prep_for	7	SENT_20	[p1l1512t1867r2138b1946],
16	small	JJ	O	small	amod	20	SENT_20	[p1l1512t1867r2138b1946],
17	—	NN	O	—	nn	20	SENT_20	[p1l1512t1867r2138b1946],
18	cell	NN	O	cell	nn	20	SENT_20	[p1l1512t1867r2138b1946],
19	lung	NN	O	lung	nn	20	SENT_20	[p1l9t1995r201b2096],
20	cancer	NN	O	cancer	dep	15	SENT_20	[p1l222t2021r494b2073],
21	is	VBZ	O	be	_	0	SENT_20	[p1l514t1996r578b2073],
22	about	IN	O	about	_	0	SENT_20	[p1l602t1995r844b2074],
23	20	CD	PERCENT	20	num	24	SENT_20	[p1l862t2001r962b2074],
24	percent	NN	PERCENT	percent	prep_about	21	SENT_20	[p1l984t2002r1365b2095],
25	?	.	O	?	_	0	SENT_20	[p1l984t2002r1365b2095],

1	Only	RB	O	only	advmod	2	SENT_21	[p1l1388t1995r1588b2095],
2	tumors	NNS	O	tumor	nsubjpass	16	SENT_21	[p1l1607t2012r1906b2074],
3	from	IN	O	from	_	0	SENT_21	[p1l1931t1994r2137b2074],
4	a	DT	O	a	det	6	SENT_21	[p1l9t2149r54b2201],
5	small	JJ	O	small	amod	6	SENT_21	[p1l75t2123r300b2201],
6	cohort	NN	O	cohort	prep_from	2	SENT_21	[p1l322t2123r599b2202],
7	of	IN	O	of	_	0	SENT_21	[p1l615t2122r715b2202],
8	patients	NNS	O	patient	prep_of	6	SENT_21	[p1l717t2124r1048b2223],
9	who	WP	O	who	nsubj	10	SENT_21	[p1l1067t2123r1249b2202],
10	had	VBD	O	have	rcmod	8	SENT_21	[p1l1271t2123r1425b2202],
11	a	DT	O	a	det	12	SENT_21	[p1l1446t2149r1491b2201],
12	response	NN	O	response	dobj	10	SENT_21	[p1l1510t2149r1886b2223],
13	to	TO	O	to	_	0	SENT_21	[p1l1908t2140r1986b2202],
14	geﬁtinib	NN	O	geﬁtinib	prep_to	12	SENT_21	[p1l2008t2149r2135b2224, p1l10t2250r263b2330],
15	were	VBD	O	be	auxpass	16	SENT_21	[p1l287t2277r489b2330],
16	studied	VBN	O	study	_	0	SENT_21	[p1l518t2251r826b2330],
17	for	IN	O	for	_	0	SENT_21	[p1l854t2250r977b2329],
18	the	DT	O	the	det	20	SENT_21	[p1l1004t2251r1133b2329],
19	speciﬁc	NN	O	speciﬁc	nn	20	SENT_21	[p1l1163t2250r1482b2351],
20	mutations	NNS	O	mutation	prep_for	16	SENT_21	[p1l1509t2252r1966b2347],
21	,	,	O	,	_	0	SENT_21	[p1l1509t2252r1966b2347],
22	but	CC	O	but	_	0	SENT_21	[p1l2001t2251r2142b2330],
23	all	DT	O	all	det	24	SENT_21	[p1l9t2379r108b2456],
24	patients	NNS	O	patient	nsubj	29	SENT_21	[p1l134t2380r469b2478],
25	except	IN	O	except	_	0	SENT_21	[p1l500t2395r771b2478],
26	one	CD	NUMBER	one	prep_except	24	SENT_21	[p1l794t2404r946b2457],
27	had	VBD	O	have	aux	29	SENT_21	[p1l974t2379r1129b2457],
28	also	RB	O	also	advmod	29	SENT_21	[p1l1156t2379r1324b2457],
29	received	VBN	O	receive	conj_but	16	SENT_21	[p1l1353t2379r1695b2458],
30	prior	RB	O	prior	prep	29	SENT_21	[p1l1721t2380r1934b2478],
31	chemotherapy	NN	O	chemotherapy	pobj	30	SENT_21	[p1l1959t2379r2135b2456, p1l10t2507r476b2607],
32	.	.	O	.	_	0	SENT_21	[p1l1959t2379r2135b2456, p1l10t2507r476b2607],

1	Although	IN	O	although	mark	4	SENT_22	[p1l500t2507r897b2608],
2	the	DT	O	the	det	3	SENT_22	[p1l920t2507r1048b2585],
3	authors	NNS	O	author	nsubj	4	SENT_22	[p1l1070t2507r1386b2586],
4	describe	VBP	O	describe	advcl	29	SENT_22	[p1l1411t2507r1758b2586],
5	Patient	NN	O	patient	dobj	4	SENT_22	[p1l1779t2508r2072b2585],
6	6	CD	NUMBER	6	num	5	SENT_22	[p1l2090t2512r2136b2586],
7	as	IN	O	as	_	0	SENT_22	[p1l9t2661r95b2713],
8	“	CD	NUMBER	“	num	10	SENT_22	[p1l134t2636r830b2735],
9	representative	JJ	O	representative	amod	10	SENT_22	[p1l134t2636r830b2735],
10	”	NN	O	”	prep_as	5	SENT_22	[p1l134t2636r830b2735],
11	of	IN	O	of	_	0	SENT_22	[p1l869t2634r971b2714],
12	the	DT	O	the	det	13	SENT_22	[p1l986t2635r1118b2713],
13	cohort	NN	O	cohort	prep_of	10	SENT_22	[p1l1152t2635r1456b2731],
14	,	,	O	,	_	0	SENT_22	[p1l1152t2635r1456b2731],
15	the	DT	O	the	det	16	SENT_22	[p1l1496t2635r1628b2713],
16	percentage	NN	O	percentage	nsubjpass	29	SENT_22	[p1l1660t2652r2135b2736],
17	of	IN	O	of	_	0	SENT_22	[p1l11t2762r112b2842],
18	other	JJ	O	other	amod	19	SENT_22	[p1l118t2763r346b2842],
19	patients	NNS	O	patient	prep_of	16	SENT_22	[p1l364t2764r707b2863],
20	who	WP	O	who	nsubj	22	SENT_22	[p1l727t2763r913b2843],
21	previously	RB	DATE	previously	advmod	22	SENT_22	[p1l935t2763r1380b2863],
22	had	VBD	O	have	rcmod	19	SENT_22	[p1l1398t2763r1556b2841],
23	a	DT	O	a	det	24	SENT_22	[p1l1577t2789r1622b2841],
24	response	NN	O	response	dobj	22	SENT_22	[p1l1643t2789r2031b2863],
25	to	TO	O	to	_	0	SENT_22	[p1l2054t2780r2134b2842],
26	chemotherapy	NN	O	chemotherapy	prep_to	24	SENT_22	[p1l11t2891r606b2991],
27	is	VBZ	O	be	auxpass	29	SENT_22	[p1l621t2892r685b2969],
28	not	RB	O	not	neg	29	SENT_22	[p1l707t2908r848b2970],
29	reported	VBN	O	report	_	0	SENT_22	[p1l863t2891r1237b2991],
30	.	.	O	.	_	0	SENT_22	[p1l863t2891r1237b2991],

1	If	IN	O	if	mark	12	SENT_23	[p1l1261t2890r1341b2968],
2	the	DT	O	the	det	3	SENT_23	[p1l1342t2891r1469b2969],
3	rate	NN	O	rate	nsubj	12	SENT_23	[p1l1489t2908r1643b2969],
4	of	IN	O	of	_	0	SENT_23	[p1l1664t2890r1763b2970],
5	response	NN	O	response	prep_of	3	SENT_23	[p1l1764t2917r2137b2991],
6	to	TO	O	to	aux	7	SENT_23	[p1l11t3036r89b3098],
7	ﬁrst	VB	O	ﬁrst	infmod	5	SENT_23	[p1l109t3018r463b3097],
8	—	CD	NUMBER	—	num	10	SENT_23	[p1l109t3018r463b3097],
9	line	NN	O	line	nn	10	SENT_23	[p1l109t3018r463b3097],
10	chemotherapy	NN	O	chemotherapy	dobj	7	SENT_23	[p1l484t3019r1082b3119],
11	was	VBD	O	be	cop	12	SENT_23	[p1l1093t3045r1252b3098],
12	high	JJ	O	high	advcl	32	SENT_23	[p1l1274t3019r1464b3120],
13	for	IN	O	for	_	0	SENT_23	[p1l1483t3018r1604b3098],
14	the	DT	O	the	det	16	SENT_23	[p1l1621t3019r1749b3097],
15	other	JJ	O	other	amod	16	SENT_23	[p1l1769t3019r1990b3098],
16	patients	NNS	O	patient	prep_for	12	SENT_23	[p1l2005t3045r2136b3119, p1l11t3148r237b3225],
17	in	IN	O	in	_	0	SENT_23	[p1l259t3148r339b3224],
18	the	DT	O	the	det	19	SENT_23	[p1l360t3147r489b3225],
19	cohort	NN	O	cohort	prep_in	16	SENT_23	[p1l512t3147r791b3226],
20	who	WP	O	who	nsubj	21	SENT_23	[p1l802t3147r986b3226],
21	had	VBD	O	have	rcmod	19	SENT_23	[p1l1009t3147r1164b3226],
22	a	DT	O	a	det	23	SENT_23	[p1l1185t3173r1229b3225],
23	response	NN	O	response	dobj	21	SENT_23	[p1l1248t3173r1628b3247],
24	to	TO	O	to	_	0	SENT_23	[p1l1650t3164r1729b3226],
25	geﬁtinib	NN	O	geﬁtinib	prep_to	23	SENT_23	[p1l1751t3146r2131b3248],
26	,	,	O	,	_	0	SENT_23	[p1l1751t3146r2131b3248],
27	the	DT	O	the	det	29	SENT_23	[p1l11t3275r140b3353],
28	speciﬁc	NN	O	speciﬁc	nn	29	SENT_23	[p1l176t3274r494b3375],
29	mutations	NNS	O	mutation	nsubj	32	SENT_23	[p1l528t3276r959b3354],
30	may	MD	O	may	aux	32	SENT_23	[p1l996t3301r1172b3375],
31	be	VB	O	be	cop	32	SENT_23	[p1l1203t3275r1299b3354],
32	predictive	JJ	O	predictive	_	0	SENT_23	[p1l1332t3275r1744b3375],
33	of	IN	O	of	_	0	SENT_23	[p1l1779t3274r1880b3354],
34	either	CC	O	either	preconj	35	SENT_23	[p1l1896t3275r2139b3353],
35	chemotherapy	NN	O	chemotherapy	prep_of	32	SENT_23	[p1l11t3403r618b3503],
36	or	CC	O	or	_	0	SENT_23	[p1l636t3429r725b3482],
37	geﬁtinib	NN	O	geﬁtinib	nn	38	SENT_23	[p1l743t3402r1098b3504],
38	sensitivity	NN	O	sensitivity	prep_of	32	SENT_23	[p1l1123t3404r1554b3503],
39	,	,	O	,	_	0	SENT_23	[p1l1123t3404r1554b3503],
40	thus	RB	O	thus	advmod	41	SENT_23	[p1l1582t3403r1762b3482],
41	identifying	VBG	O	identify	partmod	32	SENT_23	[p1l1785t3402r2135b3503, p1l9t3532r147b3632],
42	a	DT	O	a	det	44	SENT_23	[p1l166t3557r210b3609],
43	distinct	JJ	O	distinct	amod	44	SENT_23	[p1l233t3531r548b3610],
44	subgroup	NN	O	subgroup	dobj	41	SENT_23	[p1l567t3531r967b3632],
45	of	IN	O	of	_	0	SENT_23	[p1l991t3530r1092b3610],
46	patients	NNS	O	patient	prep_of	44	SENT_23	[p1l1094t3532r1425b3631],
47	with	IN	O	with	_	0	SENT_23	[p1l1446t3531r1634b3610],
48	non	JJ	O	non	amod	52	SENT_23	[p1l1657t3531r2135b3610, p1l11t3659r152b3737],
49	—	NN	O	—	nn	52	SENT_23	[p1l1657t3531r2135b3610, p1l11t3659r152b3737],
50	smallcell	NN	O	smallcell	nn	52	SENT_23	[p1l1657t3531r2135b3610, p1l11t3659r152b3737],
51	lung	NN	O	lung	nn	52	SENT_23	[p1l176t3659r370b3760],
52	cancer	NN	O	cancer	prep_with	46	SENT_23	[p1l393t3685r684b3738],
53	.	.	O	.	_	0	SENT_23	[p1l393t3685r684b3738],

1	Steven	NNP	PERSON	Steven	nn	3	SENT_24	[p2l12t30r296b103],
2	M.	NNP	PERSON	M.	nn	3	SENT_24	[p2l342t31r444b103],
3	Sorscher	NNP	PERSON	Sorscher	_	0	SENT_24	[p2l482t23r878b117],
4	,	,	O	,	_	0	SENT_24	[p2l482t23r878b117],
5	M.D.	NNP	ORGANIZATION	M.D.	nn	8	SENT_24	[p2l923t31r1129b103],
6	Marshﬁeld	NNP	ORGANIZATION	Marshﬁeld	nn	8	SENT_24	[p2l15t142r360b203],
7	Clinic	NNP	ORGANIZATION	Clinic	nn	8	SENT_24	[p2l389t142r572b203],
8	Wausau	NNP	ORGANIZATION	Wausau	appos	3	SENT_24	[p2l7t232r286b297],
9	,	,	O	,	_	0	SENT_24	[p2l7t232r286b297],
10	WI	NNP	O	WI	appos	3	SENT_24	[p2l311t232r396b287],
11	54401	CD	NUMBER	54401	num	10	SENT_24	[p2l427t230r619b287],
12	sorscher.steven@marshﬁe	JJ	O	sorscher.steven@marshﬁe	amod	14	SENT_24	[p2l11t313r1266b393],
13	|	NN	O	|	nn	14	SENT_24	[p2l11t313r1266b393],
14	dc	NN	O	dc	dep	10	SENT_24	[p2l11t313r1266b393],
15	|	CD	NUMBER	|	num	16	SENT_24	[p2l11t313r1266b393],
16	inic.org	NN	O	inic.org	dep	3	SENT_24	[p2l11t313r1266b393],
17	1	CD	NUMBER	1	dep	16	SENT_24	[p2l12t420r60b471],
18	.	.	O	.	_	0	SENT_24	[p2l12t420r60b471],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_25	[p2l137t413r327b488],
2	T	NN	O	t	nn	3	SENT_25	[p2l344t417r428b484],
3	]	NN	O	]	_	0	SENT_25	[p2l344t417r428b484],
4	,	,	O	,	_	0	SENT_25	[p2l344t417r428b484],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_25	[p2l451t413r571b471],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_25	[p2l589t418r719b484],
7	,	,	O	,	_	0	SENT_25	[p2l589t418r719b484],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_25	[p2l745t413r1002b472],
9	R	NNP	PERSON	R	appos	3	SENT_25	[p2l1019t418r1084b485],
10	,	,	O	,	_	0	SENT_25	[p2l1019t418r1084b485],
11	et	FW	O	et	nn	12	SENT_25	[p2l1108t425r1167b471],
12	al.	FW	O	al.	appos	3	SENT_25	[p2l1182t413r1252b472],
13	.	.	O	.	_	0	SENT_25	[p2l1182t413r1252b472],

1	Activating	VBG	O	activate	amod	2	SENT_26	[p2l1274t413r1598b488],
2	mutations	NNS	O	mutation	_	0	SENT_26	[p2l1615t413r1938b473],
3	in	IN	O	in	_	0	SENT_26	[p2l1958t414r2019b471],
4	the	DT	O	the	det	7	SENT_26	[p2l2039t413r2137b471],
5	epidermal	JJ	O	epidermal	amod	7	SENT_26	[p2l10t500r330b575],
6	growth	NN	O	growth	nn	7	SENT_26	[p2l371t500r599b575],
7	factor	NN	O	factor	prep_in	2	SENT_26	[p2l640t499r825b559],
8	receptor	NN	O	receptor	nn	10	SENT_26	[p2l864t512r1129b575],
9	underlying	VBG	O	underlie	amod	10	SENT_26	[p2l1168t500r1514b575],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_26	[p2l1553t501r2032b575],
11	of	IN	O	of	_	0	SENT_26	[p2l2076t499r2152b559],
12	non	JJ	O	non	amod	18	SENT_26	[p2l9t587r484b646],
13	—	JJ	O	—	amod	18	SENT_26	[p2l9t587r484b646],
14	small	JJ	O	small	amod	18	SENT_26	[p2l9t587r484b646],
15	—	NN	O	—	nn	18	SENT_26	[p2l9t587r484b646],
16	cell	NN	O	cell	nn	18	SENT_26	[p2l9t587r484b646],
17	lung	NN	O	lung	nn	18	SENT_26	[p2l514t587r660b662],
18	cancer	NN	O	cancer	prep_of	10	SENT_26	[p2l690t606r896b645],
19	to	TO	O	to	_	0	SENT_26	[p2l926t599r986b646],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_26	[p2l1018t586r1302b662],
21	.	.	O	.	_	0	SENT_26	[p2l1018t586r1302b662],

1	N	NN	O	n	nn	2	SENT_27	[p2l1337t592r1393b646],
2	EnglJ	NN	O	englj	nsubj	3	SENT_27	[p2l1422t587r1620b662],
3	Med	VBD	O	med	_	0	SENT_27	[p2l1648t587r1788b646],
4	2004	CD	DATE	2004	dobj	3	SENT_27	[p2l1820t591r2135b658],
5	;	:	O	;	_	0	SENT_27	[p2l1820t591r2135b658],
6	350	CD	NUMBER	350	num	8	SENT_27	[p2l1820t591r2135b658],
7	:	:	O	:	_	0	SENT_27	[p2l1820t591r2135b658],
8	2129-39	CD	NUMBER	2129-39	dep	4	SENT_27	[p2l9t688r288b744],
9	.	.	O	.	_	0	SENT_27	[p2l9t688r288b744],

1	2	LS	NUMBER	2	_	0	SENT_28	[p2l8t779r60b830],
2	.	.	O	.	_	0	SENT_28	[p2l8t779r60b830],

1	Schiller	NNP	PERSON	Schiller	nn	2	SENT_29	[p2l140t771r379b830],
2	JH	NNP	O	JH	_	0	SENT_29	[p2l390t776r493b842],
3	,	,	O	,	_	0	SENT_29	[p2l390t776r493b842],
4	Harrington	NNP	PERSON	Harrington	nn	5	SENT_29	[p2l518t772r878b846],
5	D	NNP	O	D	appos	2	SENT_29	[p2l898t776r965b842],
6	,	,	O	,	_	0	SENT_29	[p2l898t776r965b842],
7	Belani	NNP	PERSON	Belani	nn	8	SENT_29	[p2l990t771r1189b830],
8	CP	NNP	O	CP	appos	2	SENT_29	[p2l1210t775r1306b842],
9	,	,	O	,	_	0	SENT_29	[p2l1210t775r1306b842],
10	et	FW	O	et	nn	11	SENT_29	[p2l1333t784r1390b829],
11	al.	FW	O	al.	appos	2	SENT_29	[p2l1408t771r1478b830],
12	.	.	O	.	_	0	SENT_29	[p2l1408t771r1478b830],

1	Comparison	NN	O	comparison	_	0	SENT_30	[p2l1505t772r1899b846],
2	of	IN	O	of	_	0	SENT_30	[p2l1922t770r1997b830],
3	four	CD	NUMBER	four	num	5	SENT_30	[p2l2006t770r2139b831],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_30	[p2l10t858r466b933],
5	regimens	NNS	O	regimen	prep_of	1	SENT_30	[p2l488t859r783b933],
6	for	IN	O	for	_	0	SENT_30	[p2l810t857r902b917],
7	advanced	JJ	O	advanced	amod	9	SENT_30	[p2l926t858r1220b918],
8	non	JJ	O	non	amod	9	SENT_30	[p2l1245t858r1721b917],
9	—	NN	O	—	prep_for	1	SENT_30	[p2l1245t858r1721b917],
10	small	JJ	O	small	amod	14	SENT_30	[p2l1245t858r1721b917],
11	—	NN	O	—	nn	14	SENT_30	[p2l1245t858r1721b917],
12	cell	NN	O	cell	nn	14	SENT_30	[p2l1245t858r1721b917],
13	lung	NN	O	lung	nn	14	SENT_30	[p2l1745t858r1891b933],
14	cancer	NN	O	cancer	dep	9	SENT_30	[p2l1915t877r2133b917],
15	.	.	O	.	_	0	SENT_30	[p2l1915t877r2133b917],

1	N	NN	O	n	nn	3	SENT_31	[p2l7t960r64b1015],
2	Engll	NNP	O	Engll	nn	3	SENT_31	[p2l80t955r265b1030],
3	Med	NNP	O	Med	_	0	SENT_31	[p2l280t955r420b1014],
4	2002	CD	DATE	2002	num	3	SENT_31	[p2l439t959r920b1026],
5	;	:	O	;	_	0	SENT_31	[p2l439t959r920b1026],
6	346:92	CD	NUMBER	346:92	number	7	SENT_31	[p2l439t959r920b1026],
7	—	CD	NUMBER	—	dep	3	SENT_31	[p2l439t959r920b1026],
8	8	CD	NUMBER	8	dep	7	SENT_31	[p2l439t959r920b1026],
9	.	.	O	.	_	0	SENT_31	[p2l439t959r920b1026],

1	TO	TO	O	to	aux	3	SENT_32	[p2l8t1252r109b1302],
2	THE	DT	O	the	det	3	SENT_32	[p2l136t1254r287b1302],
3	EDITOR	NN	O	editor	_	0	SENT_32	[p2l322t1252r625b1303],
4	:	:	O	:	_	0	SENT_32	[p2l322t1252r625b1303],
5	Lynch	NNP	PERSON	Lynch	dep	3	SENT_32	[p2l654t1224r906b1325],
6	et	FW	O	et	nn	7	SENT_32	[p2l942t1241r1018b1303],
7	al.	FW	O	al.	dep	5	SENT_32	[p2l1048t1224r1141b1303],
8	and	CC	O	and	_	0	SENT_32	[p2l1181t1224r1337b1303],
9	Paez	NNP	PERSON	Paez	conj_and	3	SENT_32	[p2l1371t1231r1562b1303],
10	et	FW	O	et	nn	11	SENT_32	[p2l1598t1241r1674b1303],
11	al.	FW	O	al.	dep	9	SENT_32	[p2l1703t1224r1844b1303],
12	1	CD	NUMBER	1	num	13	SENT_32	[p2l1703t1224r1844b1303],
13	report	NN	O	report	dep	24	SENT_32	[p2l1878t1241r2141b1325],
14	that	IN	O	that	dep	24	SENT_32	[p2l11t1352r178b1431],
15	mutations	NNS	O	mutation	nsubjpass	24	SENT_32	[p2l198t1353r629b1431],
16	in	IN	O	in	_	0	SENT_32	[p2l656t1353r738b1430],
17	the	DT	O	the	det	19	SENT_32	[p2l764t1352r893b1431],
18	EGFRkinase	NN	MISC	egfrkinase	nn	19	SENT_32	[p2l918t1352r1463b1436],
19	domain	NN	O	domain	prep_in	15	SENT_32	[p2l1490t1352r1814b1431],
20	in	IN	O	in	_	0	SENT_32	[p2l1839t1353r1921b1430],
21	lung	NN	O	lung	nn	22	SENT_32	[p2l1945t1352r2140b1453],
22	cancers	NNS	O	cancer	prep_in	19	SENT_32	[p2l11t1506r325b1559],
23	are	VBP	O	be	auxpass	24	SENT_32	[p2l351t1506r477b1559],
24	associated	VBN	O	associate	dep	3	SENT_32	[p2l502t1480r938b1559],
25	with	IN	O	with	_	0	SENT_32	[p2l960t1480r1149b1559],
26	responsiveness	NN	O	responsiveness	prep_with	24	SENT_32	[p2l1174t1481r1813b1581],
27	to	TO	O	to	_	0	SENT_32	[p2l1840t1497r1919b1559],
28	geﬁtinib	NN	O	geﬁtinib	prep_to	24	SENT_32	[p2l1945t1480r2135b1581, p2l11t1608r228b1687],
29	.	.	O	.	_	0	SENT_32	[p2l1945t1480r2135b1581, p2l11t1608r228b1687],

1	We	PRP	O	we	nsubj	2	SENT_33	[p2l269t1616r402b1687],
2	performed	VBD	O	perform	_	0	SENT_33	[p2l441t1608r890b1709],
3	a	DT	O	a	det	5	SENT_33	[p2l929t1635r973b1687],
4	mutational	JJ	O	mutational	amod	5	SENT_33	[p2l1010t1608r1475b1687],
5	analysis	NN	O	analysis	dobj	2	SENT_33	[p2l1513t1608r1844b1709],
6	of	IN	O	of	_	0	SENT_33	[p2l1886t1608r1986b1687],
7	the	DT	O	the	det	9	SENT_33	[p2l2007t1608r2136b1687],
8	EGFRkinase	NN	O	egfrkinase	nn	9	SENT_33	[p2l8t1736r553b1820],
9	region	NN	O	region	prep_of	5	SENT_33	[p2l579t1737r852b1837],
10	on	IN	O	on	_	0	SENT_33	[p2l878t1762r985b1815],
11	tumor	NN	O	tumor	nn	12	SENT_33	[p2l1011t1753r1274b1815],
12	tissue	NN	O	tissue	prep_on	2	SENT_33	[p2l1297t1737r1539b1815],
13	from	IN	O	from	_	0	SENT_33	[p2l1564t1736r1771b1815],
14	nine	CD	NUMBER	nine	num	15	SENT_33	[p2l1797t1737r1981b1815],
15	patients	NNS	O	patient	prep_from	2	SENT_33	[p2l2006t1762r2136b1837, p2l21t1865r250b1943],
16	with	IN	O	with	_	0	SENT_33	[p2l277t1864r469b1943],
17	an	DT	O	a	det	21	SENT_33	[p2l500t1890r601b1943],
18	event	NN	O	event	nn	21	SENT_33	[p2l633t1864r1057b1943],
19	—	CD	NUMBER	—	num	21	SENT_33	[p2l633t1864r1057b1943],
20	free	JJ	O	free	amod	21	SENT_33	[p2l633t1864r1057b1943],
21	survival	NN	O	survival	prep_with	15	SENT_33	[p2l1090t1864r1415b1943],
22	of	IN	O	of	_	0	SENT_33	[p2l1447t1864r1548b1943],
23	more	JJR	O	more	mwe	24	SENT_33	[p2l1561t1890r1784b1943],
24	than	IN	O	than	quantmod	25	SENT_33	[p2l1816t1864r2007b1943],
25	24	CD	NUMBER	24	prep_of	21	SENT_33	[p2l2038t1870r2140b1943],

1	weeks	NNS	DURATION	week	_	0	SENT_34	[p2l16t1991r279b2070],
2	in	IN	O	in	_	0	SENT_34	[p2l316t1992r397b2068],
3	our	PRP$	O	we	poss	6	SENT_34	[p2l434t2017r578b2070],
4	phase	NN	O	phase	nn	6	SENT_34	[p2l610t1991r856b2091],
5	2	CD	NUMBER	2	num	6	SENT_34	[p2l893t1997r940b2068],
6	trial	NN	O	trial	prep_in	1	SENT_34	[p2l977t1991r1143b2069],
7	of	IN	O	of	_	0	SENT_34	[p2l1180t1991r1280b2069],
8	geﬁtinib	NN	O	geﬁtinib	prep_of	6	SENT_34	[p2l1298t1991r1652b2091],
9	in	IN	O	in	_	0	SENT_34	[p2l1689t1992r1770b2068],
10	patients	NNS	O	patient	prep_in	1	SENT_34	[p2l1805t1992r2139b2091],
11	with	IN	O	with	_	0	SENT_34	[p2l16t2118r204b2197],
12	glioblastoma	NN	O	glioblastoma	prep_with	10	SENT_34	[p2l256t2118r878b2218],
13	?	.	O	?	_	0	SENT_34	[p2l256t2118r878b2218],

1	N	NN	O	n	nn	3	SENT_35	[p2l928t2126r1003b2197],
2	o	NN	O	o	nn	3	SENT_35	[p2l1006t2144r1053b2196],
3	mutations	NNS	O	mutation	nsubj	13	SENT_35	[p2l1107t2119r1536b2197],
4	affecting	VBG	O	affect	partmod	3	SENT_35	[p2l1590t2118r1963b2218],
5	the	DT	O	the	det	8	SENT_35	[p2l2012t2118r2141b2196],
6	amino	NN	O	amino	nn	8	SENT_35	[p2l20t2246r288b2323],
7	acid	NN	O	acid	nn	8	SENT_35	[p2l315t2245r486b2323],
8	sequence	NN	O	sequence	dobj	4	SENT_35	[p2l514t2271r901b2345],
9	in	IN	O	in	_	0	SENT_35	[p2l928t2246r1008b2322],
10	the	DT	O	the	det	12	SENT_35	[p2l1035t2245r1164b2323],
11	kinase	NN	O	kinase	nn	12	SENT_35	[p2l1191t2245r1461b2324],
12	region	NN	O	region	prep_in	8	SENT_35	[p2l1488t2246r1760b2345],
13	were	VBD	O	be	_	0	SENT_35	[p2l1782t2271r1984b2324],
14	de	IN	O	de	amod	15	SENT_35	[p2l2011t2245r2140b2323],
15	—	CD	NUMBER	—	nsubj	16	SENT_35	[p2l2011t2245r2140b2323],
16	tected	VBN	O	tect	dep	13	SENT_35	[p2l21t2372r293b2450],
17	.	.	O	.	_	0	SENT_35	[p2l21t2372r293b2450],

1	However	RB	O	however	advmod	14	SENT_36	[p2l321t2380r712b2467],
2	,	,	O	,	_	0	SENT_36	[p2l321t2380r712b2467],
3	our	PRP$	O	we	poss	4	SENT_36	[p2l741t2398r886b2451],
4	experience	NN	O	experience	nsubj	14	SENT_36	[p2l906t2373r1354b2472],
5	with	IN	O	with	_	0	SENT_36	[p2l1373t2372r1562b2451],
6	EGFRimmu	NN	O	egfrimmu	nn	8	SENT_36	[p2l1584t2373r2140b2455],
7	—	CD	NUMBER	—	num	8	SENT_36	[p2l1584t2373r2140b2455],
8	nolocalization	NN	O	nolocalization	prep_with	4	SENT_36	[p2l20t2499r623b2577],
9	in	IN	O	in	_	0	SENT_36	[p2l655t2500r735b2576],
10	brain	NN	O	brain	nn	13	SENT_36	[p2l769t2499r988b2577],
11	and	CC	O	and	_	0	SENT_36	[p2l1020t2499r1175b2577],
12	lung	NN	O	lung	conj_and	10	SENT_36	[p2l1207t2499r1401b2599],
13	tumors	NNS	O	tumor	prep_in	8	SENT_36	[p2l1430t2516r1731b2578],
14	indicates	VBZ	O	indicate	_	0	SENT_36	[p2l1765t2499r2139b2577],
15	that	IN	O	that	complm	44	SENT_36	[p2l21t2626r187b2704],
16	the	DT	O	the	det	20	SENT_36	[p2l206t2626r335b2704],
17	cytoplasmic	JJ	O	cytoplasmic	amod	20	SENT_36	[p2l360t2626r861b2726],
18	and	CC	O	and	_	0	SENT_36	[p2l884t2626r1039b2704],
19	membranous	JJ	O	membranous	amod	20	SENT_36	[p2l1063t2626r1625b2705],
20	localization	NN	O	localization	nsubj	44	SENT_36	[p2l1650t2626r2141b2704],
21	of	IN	O	of	_	0	SENT_36	[p2l21t2752r122b2831],
22	wild	JJ	O	wild	amod	25	SENT_36	[p2l120t2753r514b2852],
23	—	NN	O	—	nn	25	SENT_36	[p2l120t2753r514b2852],
24	type	NN	O	type	nn	25	SENT_36	[p2l120t2753r514b2852],
25	EGFR	NN	ORGANIZATION	egfr	prep_of	20	SENT_36	[p2l535t2759r793b2836],
26	and	CC	O	and	_	0	SENT_36	[p2l804t2753r959b2831],
27	the	DT	O	the	det	31	SENT_36	[p2l982t2753r1111b2831],
28	constitutively	RB	O	constitutively	advmod	29	SENT_36	[p2l1134t2753r1696b2852],
29	active	JJ	O	active	amod	31	SENT_36	[p2l1713t2754r1948b2832],
30	mutant	JJ	O	mutant	amod	31	SENT_36	[p2l1970t2779r2140b2832, p2l21t2898r190b2959],
31	EGFRVIII	NN	O	egfrviius	prep_of	20	SENT_36	[p2l222t2887r613b2964],
32	in	IN	O	in	_	0	SENT_36	[p2l650t2882r731b2958],
33	brain	NN	O	brain	nn	34	SENT_36	[p2l771t2881r990b2959],
34	tumors	NNS	O	tumor	prep_in	31	SENT_36	[p2l1029t2897r1330b2960],
35	as	IN	O	as	_	0	SENT_36	[p2l1370t2907r1454b2959],
36	compared	VBN	O	compare	prepc_as	34	SENT_36	[p2l1496t2881r1918b2980],
37	with	IN	O	with	pcomp	36	SENT_36	[p2l1952t2881r2142b2960],
38	only	RB	O	only	advmod	40	SENT_36	[p2l21t3008r202b3107],
39	membranous	JJ	O	membranous	amod	40	SENT_36	[p2l220t3008r782b3086],
40	localization	NN	O	localization	pobj	37	SENT_36	[p2l805t3008r1297b3086],
41	in	IN	O	in	_	0	SENT_36	[p2l1318t3009r1399b3085],
42	lung	NN	O	lung	nn	43	SENT_36	[p2l1420t3008r1614b3108],
43	tumors	NNS	O	tumor	prep_in	40	SENT_36	[p2l1633t3024r1934b3086],
44	supports	VBZ	O	support	ccomp	14	SENT_36	[p2l1959t3034r2140b3107, p2l19t3153r235b3236],
45	additional	JJ	O	additional	amod	46	SENT_36	[p2l260t3136r687b3215],
46	differences	NNS	O	difference	dobj	44	SENT_36	[p2l710t3135r1173b3215],
47	in	IN	O	in	_	0	SENT_36	[p2l1197t3137r1278b3214],
48	the	DT	O	the	det	49	SENT_36	[p2l1302t3136r1431b3214],
49	biology	NN	O	biology	prep_in	44	SENT_36	[p2l1455t3136r1770b3237],
50	of	IN	O	of	_	0	SENT_36	[p2l1790t3135r1890b3215],
51	EGFR	NN	ORGANIZATION	egfr	prep_of	49	SENT_36	[p2l1893t3142r2152b3219],
52	between	IN	O	between	_	0	SENT_36	[p2l21t3264r370b3343],
53	these	DT	O	these	det	55	SENT_36	[p2l407t3264r625b3342],
54	tumor	NN	O	tumor	nn	55	SENT_36	[p2l662t3280r924b3343],
55	systems	NNS	O	system	prep_between	51	SENT_36	[p2l959t3281r1287b3363],
56	(	CD	NUMBER	(	num	58	SENT_36	[p2l1331t3264r1811b3354],
57	McLendon	NNP	PERSON	McLendon	nn	58	SENT_36	[p2l1331t3264r1811b3354],
58	R	NN	O	r	dep	55	SENT_36	[p2l1845t3270r1932b3347],
59	:	:	O	:	_	0	SENT_36	[p2l1845t3270r1932b3347],
60	personal	JJ	O	personal	amod	62	SENT_36	[p2l1971t3290r2140b3363, p2l22t3391r246b3469],
61	communication	NN	O	communication	nn	62	SENT_36	[p2l270t3392r998b3481],
62	)	NN	O	)	dep	55	SENT_36	[p2l270t3392r998b3481],
63	.	.	O	.	_	0	SENT_36	[p2l270t3392r998b3481],

1	In	IN	O	in	_	0	SENT_37	[p2l1026t3398r1112b3468],
2	summary	NN	O	summary	prep_in	9	SENT_37	[p2l1137t3417r1545b3490],
3	,	,	O	,	_	0	SENT_37	[p2l1137t3417r1545b3490],
4	EGFR	NN	ORGANIZATION	egfr	nsubj	9	SENT_37	[p2l1573t3397r1831b3473],
5	in	IN	O	in	_	0	SENT_37	[p2l1844t3392r1925b3468],
6	glioblastoma	NN	O	glioblastoma	prep_in	4	SENT_37	[p2l1948t3391r2140b3491, p2l21t3520r410b3599],
7	did	VBD	O	do	aux	9	SENT_37	[p2l440t3520r573b3599],
8	not	RB	O	not	neg	9	SENT_37	[p2l604t3537r747b3599],
9	have	VB	O	have	_	0	SENT_37	[p2l773t3520r961b3599],
10	mutations	NNS	O	mutation	dobj	9	SENT_37	[p2l992t3521r1422b3599],
11	in	IN	O	in	_	0	SENT_37	[p2l1455t3521r1536b3598],
12	the	DT	O	the	det	14	SENT_37	[p2l1567t3520r1696b3599],
13	kinase	NN	O	kinase	nn	14	SENT_37	[p2l1728t3520r1997b3599],
14	region	NN	O	region	prep_in	10	SENT_37	[p2l2029t3546r2140b3598, p2l20t3649r233b3749],
15	,	,	O	,	_	0	SENT_37	[p2l2029t3546r2140b3598, p2l20t3649r233b3749],

1	and	CC	O	and	cc	9	SENT_38	[p2l272t3648r428b3727],
2	any	DT	O	any	det	3	SENT_38	[p2l463t3674r610b3748],
3	activity	NN	O	activity	nsubj	9	SENT_38	[p2l640t3649r935b3748],
4	of	IN	O	of	_	0	SENT_38	[p2l966t3647r1066b3727],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_38	[p2l1083t3647r1437b3749],
6	in	IN	O	in	_	0	SENT_38	[p2l1473t3649r1554b3726],
7	glioblastoma	NN	O	glioblastoma	prep_in	5	SENT_38	[p2l1589t3648r2143b3749],
8	would	MD	O	would	aux	9	SENT_38	[p3l16t20r280b99],
9	occur	VB	O	occur	_	0	SENT_38	[p3l306t45r539b98],
10	through	IN	O	through	_	0	SENT_38	[p3l561t20r902b120],
11	an	DT	O	a	det	14	SENT_38	[p3l926t46r1026b97],
12	alternative	JJ	O	alternative	amod	14	SENT_38	[p3l1050t20r1487b98],
13	mechanism	NN	O	mechanism	nn	14	SENT_38	[p3l1511t20r2004b97],
14	reﬂective	NN	O	reﬂective	prep_through	9	SENT_38	[p3l2028t46r2140b97, p3l20t147r314b227],
15	of	IN	O	of	_	0	SENT_38	[p3l340t147r441b227],
16	important	JJ	O	important	amod	18	SENT_38	[p3l447t149r879b248],
17	pathophysiological	JJ	O	pathophysiological	amod	18	SENT_38	[p3l898t148r1706b249],
18	differences	NNS	O	difference	prep_of	14	SENT_38	[p3l1732t147r2140b227, p3l21t301r102b352],
19	between	IN	O	between	_	0	SENT_38	[p3l130t275r480b353],
20	glioblastomas	NNS	O	glioblastoma	prep_between	18	SENT_38	[p3l504t275r1098b375],
21	and	CC	O	and	_	0	SENT_38	[p3l1124t275r1280b353],
22	lung	NN	O	lung	nn	23	SENT_38	[p3l1304t275r1497b375],
23	carcinomas	NNS	O	carcinoma	prep_between	18	SENT_38	[p3l1519t276r2028b353],
24	.	.	O	.	_	0	SENT_38	[p3l1519t276r2028b353],

1	Jeremy	NNP	PERSON	Jeremy	nn	3	SENT_39	[p3l7t409r320b507],
2	N.	NNP	PERSON	N.	nn	3	SENT_39	[p3l357t409r446b481],
3	Rich	NNP	PERSON	Rich	_	0	SENT_39	[p3l490t401r692b495],
4	,	,	O	,	_	0	SENT_39	[p3l490t401r692b495],
5	M.D.	NNP	O	M.D.	nn	7	SENT_39	[p3l737t409r942b481],
6	B.	NNP	O	B.	nn	7	SENT_39	[p3l29t538r188b610],
7	|	NNP	O	|	appos	3	SENT_39	[p3l29t538r188b610],
8	<	JJR	O	<	dep	7	SENT_39	[p3l29t538r188b610],
9	.	.	O	.	_	0	SENT_39	[p3l29t538r188b610],

1	Ahmed	NNP	PERSON	Ahmed	nn	2	SENT_40	[p3l222t530r532b610],
2	Rasheed	NNP	PERSON	Rasheed	_	0	SENT_40	[p3l578t530r963b624],
3	,	,	O	,	_	0	SENT_40	[p3l578t530r963b624],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_40	[p3l1008t530r1236b610],
5	.	.	O	.	_	0	SENT_40	[p3l1008t530r1236b610],

1	Hai	NNP	PERSON	Hai	nn	2	SENT_41	[p3l29t666r169b738],
2	Yan	NNP	PERSON	Yan	_	0	SENT_41	[p3l204t666r379b752],
3	,	,	O	,	_	0	SENT_41	[p3l204t666r379b752],
4	M.D.	NNP	O	M.D.	nn	6	SENT_41	[p3l424t666r655b752],
5	,	,	O	,	_	0	SENT_41	[p3l424t666r655b752],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_41	[p3l700t658r928b738],
7	.	.	O	.	_	0	SENT_41	[p3l700t658r928b738],

1	Duke	NNP	ORGANIZATION	Duke	nn	5	SENT_42	[p3l25t800r190b860],
2	University	NNP	ORGANIZATION	University	nn	5	SENT_42	[p3l218t805r545b879],
3	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_42	[p3l572t800r823b860],
4	Center	NNP	ORGANIZATION	Center	nn	5	SENT_42	[p3l852t804r1066b860],
5	Durham	NNP	ORGANIZATION	Durham	_	0	SENT_42	[p3l25t914r309b985],
6	,	,	O	,	_	0	SENT_42	[p3l25t914r309b985],
7	NC	NNP	O	NC	nn	9	SENT_42	[p3l342t918r442b974],
8	27710	CD	NUMBER	27710	num	9	SENT_42	[p3l465t918r662b974],
9	rich0OO1@mc.duke.edu	NN	O	rich0oo1@mc.duke.edu	appos	5	SENT_42	[p3l24t1000r808b1072],
10	1	CD	NUMBER	1	dep	9	SENT_42	[p3l22t1101r70b1152],
11	.	.	O	.	_	0	SENT_42	[p3l22t1101r70b1152],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_43	[p3l147t1099r290b1152],
2	JG	NNP	O	JG	_	0	SENT_43	[p3l301t1098r402b1165],
3	,	,	O	,	_	0	SENT_43	[p3l301t1098r402b1165],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_43	[p3l416t1099r598b1162],
5	PA	NN	PERSON	pa	appos	2	SENT_43	[p3l616t1099r716b1165],
6	,	,	O	,	_	0	SENT_43	[p3l616t1099r716b1165],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_43	[p3l736t1099r843b1152],
8	JC	NNP	PERSON	JC	appos	2	SENT_43	[p3l853t1098r946b1165],
9	,	,	O	,	_	0	SENT_43	[p3l853t1098r946b1165],
10	et	FW	O	et	nn	11	SENT_43	[p3l969t1106r1026b1152],
11	al.	FW	O	al.	appos	2	SENT_43	[p3l1040t1094r1110b1153],
12	.	.	O	.	_	0	SENT_43	[p3l1040t1094r1110b1153],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_44	[p3l1131t1098r1325b1156],
2	mutations	NNS	O	mutation	_	0	SENT_44	[p3l1335t1094r1657b1154],
3	in	IN	O	in	_	0	SENT_44	[p3l1676t1095r1737b1152],
4	lung	NN	O	lung	nn	5	SENT_44	[p3l1755t1094r1900b1169],
5	cancer	NN	O	cancer	prep_in	2	SENT_44	[p3l1916t1113r2139b1153],
6	:	:	O	:	_	0	SENT_44	[p3l1916t1113r2139b1153],
7	correlation	NN	O	correlation	dep	2	SENT_44	[p3l20t1181r365b1240],
8	with	IN	O	with	_	0	SENT_44	[p3l379t1181r521b1241],
9	clinical	JJ	O	clinical	amod	10	SENT_44	[p3l539t1181r764b1239],
10	response	NN	O	response	prep_with	7	SENT_44	[p3l781t1200r1065b1256],
11	to	TO	O	to	_	0	SENT_44	[p3l1083t1193r1142b1240],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_44	[p3l1161t1180r1427b1256],
13	therapy	NN	O	therapy	prep_to	10	SENT_44	[p3l1445t1181r1690b1256],
14	.	.	O	.	_	0	SENT_44	[p3l1445t1181r1690b1256],

1	Science	NNP	O	Science	_	0	SENT_45	[p3l1713t1182r1947b1240],
2	2004	CD	DATE	2004	num	1	SENT_45	[p3l1965t1185r2139b1252],
3	;	:	O	;	_	0	SENT_45	[p3l1965t1185r2139b1252],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_45	[p3l20t1280r478b1335],
5	-500	CD	NUMBER	-500	dep	1	SENT_45	[p3l20t1280r478b1335],
6	.	.	O	.	_	0	SENT_45	[p3l20t1280r478b1335],

1	2	LS	NUMBER	2	_	0	SENT_46	[p3l18t1370r70b1421],
2	.	.	O	.	_	0	SENT_46	[p3l18t1370r70b1421],

1	Rich	NNP	O	Rich	nn	2	SENT_47	[p3l147t1362r292b1424],
2	JN	NN	O	jn	_	0	SENT_47	[p3l305t1367r404b1433],
3	,	,	O	,	_	0	SENT_47	[p3l305t1367r404b1433],
4	Reardon	NNP	ORGANIZATION	Reardon	nn	5	SENT_47	[p3l428t1362r698b1424],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_47	[p3l718t1367r833b1433],
6	,	,	O	,	_	0	SENT_47	[p3l718t1367r833b1433],
7	Peery	NNP	PERSON	Peery	nn	8	SENT_47	[p3l857t1367r1028b1437],
8	T	NN	O	t	appos	2	SENT_47	[p3l1043t1366r1098b1433],
9	,	,	O	,	_	0	SENT_47	[p3l1043t1366r1098b1433],
10	et	FW	O	et	nn	11	SENT_47	[p3l1124t1375r1182b1420],
11	al.	FW	O	al.	appos	2	SENT_47	[p3l1198t1362r1269b1421],
12	.	.	O	.	_	0	SENT_47	[p3l1198t1362r1269b1421],

1	Phase	NN	O	phase	nn	3	SENT_48	[p3l1293t1362r1477b1420],
2	II	CD	NUMBER	ii	num	3	SENT_48	[p3l1496t1367r1544b1420],
3	trial	NN	O	trial	_	0	SENT_48	[p3l1565t1362r1690b1420],
4	of	IN	O	of	_	0	SENT_48	[p3l1711t1361r1786b1421],
5	gefitinib	NN	O	gefitinib	prep_of	3	SENT_48	[p3l1794t1361r2060b1437],
6	in	IN	O	in	_	0	SENT_48	[p3l2081t1363r2143b1420],
7	recurrent	JJ	O	recurrent	amod	8	SENT_48	[p3l20t1461r314b1507],
8	glioblastoma	NN	O	glioblastoma	prep_in	3	SENT_48	[p3l329t1448r761b1523],
9	.	.	O	.	_	0	SENT_48	[p3l329t1448r761b1523],

1	J	NNP	O	J	nn	3	SENT_49	[p3l776t1453r804b1516],
2	Clin	NNP	O	Clin	nn	3	SENT_49	[p3l821t1448r951b1507],
3	Oncol	NNP	O	Oncol	_	0	SENT_49	[p3l969t1448r1160b1507],
4	2004	CD	DATE	2004	num	3	SENT_49	[p3l1179t1452r1698b1519],
5	;	:	O	;	_	0	SENT_49	[p3l1179t1452r1698b1519],
6	22:133	CD	NUMBER	22:133	number	7	SENT_49	[p3l1179t1452r1698b1519],
7	—	CD	NUMBER	—	dep	3	SENT_49	[p3l1179t1452r1698b1519],
8	42	CD	NUMBER	42	dep	7	SENT_49	[p3l1179t1452r1698b1519],
9	.	.	O	.	_	0	SENT_49	[p3l1179t1452r1698b1519],

1	To	TO	O	to	_	0	SENT_50	[p3l18t1743r119b1793],
2	THE	DT	O	the	det	3	SENT_50	[p3l146t1744r296b1792],
3	EDITOR	NN	O	editor	prep_to	9	SENT_50	[p3l332t1743r633b1793],
4	:	:	O	:	_	0	SENT_50	[p3l332t1743r633b1793],
5	Lynch	NNP	PERSON	Lynch	dep	3	SENT_50	[p3l662t1716r914b1815],
6	et	FW	O	et	nn	7	SENT_50	[p3l952t1732r1029b1793],
7	al.	FW	O	al.	dep	5	SENT_50	[p3l1061t1716r1155b1793],
8	elegantly	RB	O	elegantly	advmod	9	SENT_50	[p3l1198t1716r1577b1816],
9	demonstrate	VBP	O	demonstrate	_	0	SENT_50	[p3l1611t1716r2141b1793],
10	the	DT	O	the	det	12	SENT_50	[p3l21t1843r148b1921],
11	presence	NN	O	presence	nn	12	SENT_50	[p3l166t1869r531b1943],
12	ofgain	NN	O	ofgain	dobj	9	SENT_50	[p3l552t1842r1335b1944],
13	—	CD	NUMBER	—	num	15	SENT_50	[p3l552t1842r1335b1944],
14	of-function	NN	O	of-function	nn	15	SENT_50	[p3l552t1842r1335b1944],
15	mutations	NNS	O	mutation	nsubj	9	SENT_50	[p3l1354t1844r1776b1922],
16	of	IN	O	of	_	0	SENT_50	[p3l1799t1842r1898b1921],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_50	[p3l1898t1848r2153b1926],
18	in	IN	O	in	_	0	SENT_50	[p3l20t1972r100b2047],
19	patients	NNS	O	patient	prep_in	15	SENT_50	[p3l118t1972r444b2070],
20	with	IN	O	with	_	0	SENT_50	[p3l461t1971r646b2049],
21	non	JJ	O	non	amod	27	SENT_50	[p3l665t1971r1282b2048],
22	—	JJ	O	—	amod	27	SENT_50	[p3l665t1971r1282b2048],
23	small	JJ	O	small	amod	27	SENT_50	[p3l665t1971r1282b2048],
24	—	NN	O	—	nn	27	SENT_50	[p3l665t1971r1282b2048],
25	cell	NN	O	cell	nn	27	SENT_50	[p3l665t1971r1282b2048],
26	lung	NN	O	lung	nn	27	SENT_50	[p3l1300t1971r1491b2071],
27	cancer	NN	O	cancer	prep_with	19	SENT_50	[p3l1507t1996r1777b2048],
28	who	WP	O	who	nsubj	29	SENT_50	[p3l1788t1971r1969b2049],
29	had	VBD	O	have	rcmod	15	SENT_50	[p3l1990t1971r2143b2048],
30	a	DT	O	a	det	31	SENT_50	[p3l20t2124r64b2176],
31	response	NN	O	response	dobj	29	SENT_50	[p3l83t2124r458b2198],
32	to	TO	O	to	_	0	SENT_50	[p3l479t2114r557b2176],
33	geﬁtinib	NN	O	geﬁtinib	prep_to	31	SENT_50	[p3l579t2097r954b2199],
34	.	.	O	.	_	0	SENT_50	[p3l579t2097r954b2199],

1	However	RB	O	however	advmod	7	SENT_51	[p3l979t2105r1366b2193],
2	,	,	O	,	_	0	SENT_51	[p3l979t2105r1366b2193],
3	the	DT	O	the	det	4	SENT_51	[p3l1393t2098r1521b2176],
4	authors	NNS	O	author	nsubj	7	SENT_51	[p3l1541t2098r1857b2177],
5	do	VBP	O	do	aux	7	SENT_51	[p3l1881t2098r1983b2176],
6	not	RB	O	not	neg	7	SENT_51	[p3l2005t2115r2147b2176],
7	mention	VB	O	mention	_	0	SENT_51	[p3l20t2228r377b2305],
8	whether	IN	O	whether	complm	10	SENT_51	[p3l404t2227r754b2306],
9	there	EX	O	there	expl	10	SENT_51	[p3l784t2227r995b2305],
10	were	VBD	O	be	ccomp	7	SENT_51	[p3l1023t2253r1224b2306],
11	correlations	NNS	O	correlation	nsubj	10	SENT_51	[p3l1257t2227r1758b2305],
12	between	IN	O	between	_	0	SENT_51	[p3l1792t2227r2142b2306],
13	mutational	JJ	O	mutational	amod	14	SENT_51	[p3l20t2355r484b2434],
14	ﬁndings	NNS	O	ﬁndings	prep_between	11	SENT_51	[p3l506t2354r855b2456],
15	and	CC	O	and	_	0	SENT_51	[p3l879t2355r1035b2433],
16	the	DT	O	the	det	17	SENT_51	[p3l1057t2355r1186b2433],
17	results	NNS	O	result	nsubj	10	SENT_51	[p3l1209t2355r1486b2434],
18	of	IN	O	of	_	0	SENT_51	[p3l1510t2354r1611b2433],
19	immunohistochemical	JJ	O	immunohistochemical	amod	20	SENT_51	[p3l1614t2355r2140b2434, p3l21t2482r484b2560],
20	studies	NNS	O	study	prep_of	17	SENT_51	[p3l515t2482r808b2561],
21	or	CC	O	or	_	0	SENT_51	[p3l840t2507r929b2560],
22	ﬂuorescence	NN	O	ﬂuorescence	conj_or	20	SENT_51	[p3l956t2481r1487b2561],
23	in	FW	O	in	prep	20	SENT_51	[p3l1516t2483r1597b2558],
24	situ	FW	O	situ	pobj	23	SENT_51	[p3l1629t2483r1780b2561],
25	hybridization	NN	O	hybridization	nn	28	SENT_51	[p3l1809t2482r2140b2581, p3l20t2611r278b2687],
26	(	CD	NUMBER	(	num	28	SENT_51	[p3l304t2615r599b2705],
27	FISH	NN	O	fish	nn	28	SENT_51	[p3l304t2615r599b2705],
28	)	NN	O	)	tmod	20	SENT_51	[p3l304t2615r599b2705],
29	,	,	O	,	_	0	SENT_51	[p3l304t2615r599b2705],
30	the	DT	O	the	det	34	SENT_51	[p3l626t2610r754b2687],
31	most	RBS	O	most	advmod	33	SENT_51	[p3l775t2626r990b2687],
32	commonly	RB	O	commonly	advmod	33	SENT_51	[p3l1006t2610r1458b2709],
33	used	VBN	O	use	amod	34	SENT_51	[p3l1474t2610r1666b2688],
34	techniques	NNS	O	technique	appos	28	SENT_51	[p3l1688t2610r2140b2709],
35	for	IN	O	for	_	0	SENT_51	[p3l20t2737r143b2816],
36	detecting	VBG	O	detect	prepc_for	7	SENT_51	[p3l179t2738r570b2839],
37	EGFR	NN	ORGANIZATION	egfr	dobj	36	SENT_51	[p3l604t2743r876b2821],
38	.	.	O	.	_	0	SENT_51	[p3l604t2743r876b2821],

1	In	IN	O	in	_	0	SENT_52	[p3l919t2745r1006b2815],
2	fact	NN	O	fact	prep_in	5	SENT_52	[p3l1044t2737r1218b2834],
3	,	,	O	,	_	0	SENT_52	[p3l1044t2737r1218b2834],
4	we	PRP	O	we	nsubj	5	SENT_52	[p3l1258t2764r1376b2817],
5	observed	VBD	O	observe	_	0	SENT_52	[p3l1416t2738r1790b2817],
6	that	IN	O	that	complm	9	SENT_52	[p3l1829t2738r1996b2816],
7	responsive	JJ	O	responsive	amod	8	SENT_52	[p3l2029t2764r2140b2816, p3l22t2867r386b2966],
8	cases	NNS	O	case	nsubj	9	SENT_52	[p3l418t2892r635b2944],
9	had	VBD	O	have	ccomp	5	SENT_52	[p3l668t2866r823b2944],
10	heterogeneous	JJ	O	heterogeneous	amod	11	SENT_52	[p3l853t2866r1474b2967],
11	results	NNS	O	result	dobj	9	SENT_52	[p3l1507t2866r1784b2945],
12	of	IN	O	of	_	0	SENT_52	[p3l1818t2865r1918b2944],
13	FISH	NN	O	fish	prep_of	11	SENT_52	[p3l1929t2871r2140b2944],

1	1260	CD	DATE	1260	num	4	SENT_53	[p3l149t3045r225b3067],
2	N	NN	O	n	nn	4	SENT_53	[p3l865t3048r879b3063],
3	ENGLJ	NN	O	englj	nn	4	SENT_53	[p3l894t3047r978b3069],
4	MED	NN	O	med	_	0	SENT_53	[p3l993t3048r1046b3063],
5	351	CD	NUMBER	351	dep	4	SENT_53	[p3l1058t3047r1134b3069],
6	;	:	O	;	_	0	SENT_53	[p3l1058t3047r1134b3069],
7	12	CD	NUMBER	12	dep	4	SENT_53	[p3l1058t3047r1134b3069],
8	WWW	NNP	O	WWW	dep	7	SENT_53	[p3l1168t3048r1263b3063],
9	.	.	O	.	_	0	SENT_53	[p3l1168t3048r1263b3063],

1	N	NN	O	n	nn	3	SENT_54	[p3l1168t3048r1263b3063],
2	EJ	NN	O	ej	nn	3	SENT_54	[p3l1271t3048r1289b3069],
3	M.ORG	NN	O	m.org	_	0	SENT_54	[p3l1297t3047r1380b3063],
4	SEPTEMBER	NN	DATE	september	dep	3	SENT_54	[p3l1418t3047r1564b3063],
5	16	CD	DATE	16	num	4	SENT_54	[p3l1577t3042r1611b3067],
6	,	,	DATE	,	_	0	SENT_54	[p3l1577t3042r1611b3067],
7	2004	CD	DATE	2004	appos	4	SENT_54	[p3l1625t3047r1692b3069],

1	The	DT	O	the	det	4	SENT_55	[p3l935t3080r986b3104],
2	New	NNP	O	New	nn	4	SENT_55	[p3l995t3081r1057b3104],
3	England	NNP	O	England	nn	4	SENT_55	[p3l1066t3080r1177b3111],
4	Journal	NNP	O	Journal	_	0	SENT_55	[p3l1186t3080r1283b3104],
5	of	IN	O	of	_	0	SENT_55	[p3l1293t3080r1322b3104],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_55	[p3l1329t3080r1454b3104],

1	Downloaded	VBN	O	download	_	0	SENT_56	[p3l377t3121r547b3144],
2	from	IN	O	from	_	0	SENT_56	[p3l556t3121r620b3144],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_56	[p3l629t3121r747b3151],
4	at	IN	O	at	_	0	SENT_56	[p3l758t3125r781b3144],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_56	[p3l789t3121r972b3144],
6	on	IN	O	on	_	0	SENT_56	[p3l981t3128r1014b3144],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_56	[p3l1022t3121r1083b3144],
8	5	CD	DATE	5	num	7	SENT_56	[p3l1135t3121r1158b3148],
9	,	,	DATE	,	_	0	SENT_56	[p3l1135t3121r1158b3148],
10	2014	CD	DATE	2014	num	7	SENT_56	[p3l1168t3121r1241b3144],
11	.	.	O	.	_	0	SENT_56	[p3l1168t3121r1241b3144],

1	For	IN	O	for	_	0	SENT_57	[p3l1251t3121r1298b3144],
2	personal	JJ	O	personal	amod	3	SENT_57	[p3l1306t3121r1418b3151],
3	use	NN	O	use	pobj	1	SENT_57	[p3l1427t3128r1471b3144],
4	only	RB	O	only	advmod	3	SENT_57	[p3l1481t3121r1545b3151],
5	.	.	O	.	_	0	SENT_57	[p3l1481t3121r1545b3151],

1	No	DT	O	no	det	3	SENT_58	[p3l1556t3121r1596b3144],
2	other	JJ	O	other	amod	3	SENT_58	[p3l1606t3121r1674b3144],
3	uses	NNS	O	use	_	0	SENT_58	[p3l1682t3128r1738b3144],
4	without	IN	O	without	_	0	SENT_58	[p3l1748t3121r1849b3144],
5	permission	NN	O	permission	prep_without	3	SENT_58	[p3l1858t3121r2010b3151],
6	.	.	O	.	_	0	SENT_58	[p3l1858t3121r2010b3151],

1	Copyright	NN	O	copyright	nsubj	6	SENT_59	[p3l727t3162r862b3193],
2	©	CD	NUMBER	©	num	1	SENT_59	[p3l871t3162r895b3186],
3	2004	CD	DATE	2004	num	5	SENT_59	[p3l905t3162r970b3186],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_59	[p3l979t3163r1064b3186],
5	u	NN	O	u	dep	1	SENT_59	[p3l1096t3170r1112b3186],
6	etts	VBZ	O	ett	_	0	SENT_59	[p3l1126t3166r1170b3186],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_59	[p3l1180t3162r1288b3186],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_59	[p3l1299t3162r1404b3193],
9	.	.	O	.	_	0	SENT_59	[p3l1299t3162r1404b3193],

1	All	DT	O	all	det	2	SENT_60	[p3l1415t3162r1456b3186],
2	rights	NNS	O	rights	nsubj	3	SENT_60	[p3l1465t3162r1540b3193],
3	reserved	VBN	O	reserve	_	0	SENT_60	[p3l1550t3162r1669b3186],
4	.	.	O	.	_	0	SENT_60	[p3l1550t3162r1669b3186],

1	CORRESPONDENCE	NN	O	correspondence	_	0	SENT_61	[p3l918t3268r1241b3287],

1	analysis	NN	O	analysis	nsubj	4	SENT_62	[p3l10t3482r366b3582],
2	,	,	O	,	_	0	SENT_62	[p3l10t3482r366b3582],
3	but	CC	O	but	advmod	4	SENT_62	[p3l406t3482r546b3561],
4	showed	VBD	O	show	_	0	SENT_62	[p3l576t3481r899b3561],
5	cytoplasm	NN	O	cytoplasm	nn	6	SENT_62	[p3l933t3482r1797b3582],
6	—	NN	O	—	iobj	4	SENT_62	[p3l933t3482r1797b3582],
7	restricted	JJ	O	restricted	amod	8	SENT_62	[p3l933t3482r1797b3582],
8	expression	NN	O	expression	dobj	4	SENT_62	[p3l1830t3508r2134b3582, p3l12t3609r188b3687],
9	of	IN	O	of	_	0	SENT_62	[p3l210t3608r309b3687],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	8	SENT_62	[p3l310t3614r568b3692],
11	on	IN	O	on	_	0	SENT_62	[p3l580t3634r685b3687],
12	immunohistochemical	JJ	O	immunohistochemical	amod	13	SENT_62	[p3l706t3608r1660b3688],
13	evaluation	NN	O	evaluation	prep_on	4	SENT_62	[p3l1681t3608r2131b3703],
14	;	:	O	;	_	0	SENT_62	[p3l1681t3608r2131b3703],

1	conversely	RB	O	conversely	advmod	6	SENT_63	[p4l11t24r454b124],
2	,	,	O	,	_	0	SENT_63	[p4l11t24r454b124],
3	unresponsive	JJ	O	unresponsive	amod	4	SENT_63	[p4l482t24r1033b124],
4	cases	NNS	O	case	nsubj	6	SENT_63	[p4l1056t50r1269b102],
5	were	VBD	O	be	cop	6	SENT_63	[p4l1290t50r1488b103],
6	negative	JJ	O	negative	_	0	SENT_63	[p4l1511t24r1851b124],
7	or	CC	O	or	_	0	SENT_63	[p4l1875t49r1963b102],
8	displayed	VBD	O	display	conj_or	6	SENT_63	[p4l1984t23r2135b102, p4l9t151r281b252],
9	a	DT	O	a	det	17	SENT_63	[p4l317t178r361b230],
10	cell	NN	O	cell	nn	17	SENT_63	[p4l397t151r1036b230],
11	—	NN	O	—	nn	17	SENT_63	[p4l397t151r1036b230],
12	membrane	NN	O	membrane	nn	17	SENT_63	[p4l397t151r1036b230],
13	staining	NN	O	staining	nn	17	SENT_63	[p4l1074t152r1420b252],
14	pattern	NN	O	pattern	nn	17	SENT_63	[p4l1453t168r1756b252],
15	(	NN	O	(	nn	17	SENT_63	[p4l1797t151r2134b252],
16	unpub	JJ	O	unpub	amod	17	SENT_63	[p4l1797t151r2134b252],
17	—	NN	O	—	dobj	8	SENT_63	[p4l1797t151r2134b252],
18	lished	VBN	O	lish	partmod	17	SENT_63	[p4l10t279r264b358],
19	data	NNS	O	datum	nn	20	SENT_63	[p4l299t280r534b371],
20	)	NN	O	)	dobj	18	SENT_63	[p4l299t280r534b371],
21	.	.	O	.	_	0	SENT_63	[p4l299t280r534b371],

1	In	IN	O	in	_	0	SENT_64	[p4l572t287r659b357],
2	a	DT	O	a	det	4	SENT_64	[p4l692t306r736b358],
3	similar	JJ	O	similar	amod	4	SENT_64	[p4l770t279r1065b358],
4	fashion	NN	O	fashion	prep_in	10	SENT_64	[p4l1096t279r1436b375],
5	,	,	O	,	_	0	SENT_64	[p4l1096t279r1436b375],
6	gastrointestinal	JJ	O	gastrointestinal	amod	8	SENT_64	[p4l1474t279r2136b380],
7	stromal	JJ	O	stromal	amod	8	SENT_64	[p4l12t407r335b486],
8	tumor	NN	O	tumor	nsubjpass	10	SENT_64	[p4l372t424r634b487],
9	is	VBZ	O	be	auxpass	10	SENT_64	[p4l668t408r733b486],
10	characterized	VBN	O	characterize	_	0	SENT_64	[p4l773t407r1338b486],
11	by	IN	O	by	_	0	SENT_64	[p4l1375t407r1472b508],
12	activating	VBG	O	activate	agent	10	SENT_64	[p4l1504t408r1914b508],
13	c	NN	O	c	dobj	12	SENT_64	[p4l1949t408r2140b487],
14	—	CD	NUMBER	—	num	16	SENT_64	[p4l1949t408r2140b487],
15	kit	NN	O	kit	nn	16	SENT_64	[p4l1949t408r2140b487],
16	mutations	NNS	O	mutation	tmod	12	SENT_64	[p4l11t536r513b631],
17	,1	CD	NUMBER	,1	nsubjpass	33	SENT_64	[p4l11t536r513b631],
18	but	CC	O	but	prep	17	SENT_64	[p4l548t536r688b615],
19	the	DT	O	the	det	21	SENT_64	[p4l717t536r846b614],
20	gene	NN	O	gene	nn	21	SENT_64	[p4l880t561r1079b636],
21	product	NN	O	product	dep	18	SENT_64	[p4l1112t536r1465b636],
22	,	,	O	,	_	0	SENT_64	[p4l1112t536r1465b636],
23	the	DT	O	the	det	29	SENT_64	[p4l1505t536r1634b614],
24	transmem	NN	O	transmem	nn	29	SENT_64	[p4l1669t552r2134b614],
25	—	NN	O	—	nn	29	SENT_64	[p4l1669t552r2134b614],
26	brane	NN	O	brane	nn	29	SENT_64	[p4l11t663r249b742],
27	tyrosine	NN	O	tyrosine	nn	29	SENT_64	[p4l282t664r617b764],
28	kinase	NN	O	kinase	nn	29	SENT_64	[p4l650t663r920b743],
29	KIT	NN	O	kit	appos	21	SENT_64	[p4l953t669r1125b759],
30	,	,	O	,	_	0	SENT_64	[p4l953t669r1125b759],
31	is	VBZ	O	be	auxpass	33	SENT_64	[p4l1162t664r1227b742],
32	aberrantly	RB	O	aberrantly	advmod	33	SENT_64	[p4l1261t664r1691b764],
33	expressed	VBN	O	express	rcmod	16	SENT_64	[p4l1720t663r2135b764],
34	in	IN	O	in	_	0	SENT_64	[p4l10t792r91b869],
35	the	DT	O	the	det	36	SENT_64	[p4l135t791r264b870],
36	cytoplasm	NN	O	cytoplasm	prep_in	33	SENT_64	[p4l308t792r761b892],
37	,	,	O	,	_	0	SENT_64	[p4l308t792r761b892],
38	whereas	IN	O	whereas	mark	48	SENT_64	[p4l805t792r1153b871],
39	other	JJ	O	other	amod	43	SENT_64	[p4l1199t791r1423b870],
40	KIT	NN	O	kit	nn	43	SENT_64	[p4l1462t792r1976b892],
41	—	NN	O	—	nn	43	SENT_64	[p4l1462t792r1976b892],
42	positive	JJ	O	positive	amod	43	SENT_64	[p4l1462t792r1976b892],
43	tumors	NNS	O	tumor	dep	48	SENT_64	[p4l2020t808r2134b871, p4l11t945r226b998],
44	without	IN	O	without	_	0	SENT_64	[p4l255t919r589b999],
45	c	NN	O	c	prep_without	43	SENT_64	[p4l616t919r807b999],
46	—	CD	NUMBER	—	num	47	SENT_64	[p4l616t919r807b999],
47	l	NN	O	l	tmod	43	SENT_64	[p4l616t919r807b999],
48	<	JJR	O	<	dep	36	SENT_64	[p4l616t919r807b999],
49	it	PRP	O	it	dep	50	SENT_64	[p4l616t919r807b999],
50	mutations	NNS	O	mutation	nsubj	51	SENT_64	[p4l833t920r1263b999],
51	show	VBP	O	show	ccomp	33	SENT_64	[p4l1297t919r1523b999],
52	KIT	NN	O	kit	nn	53	SENT_64	[p4l1550t925r1709b1000],
53	immunoreactivity	NN	O	immunoreactivity	dobj	51	SENT_64	[p4l1736t920r2134b999, p4l11t1048r389b1148],

1	on	IN	O	on	_	0	SENT_65	[p4l428t1073r534b1126],
2	cell	NN	O	cell	nn	3	SENT_65	[p4l576t1047r718b1126],
3	membranes	NNS	O	membrane	pobj	1	SENT_65	[p4l759t1047r1330b1126],
4	?	.	O	?	_	0	SENT_65	[p4l759t1047r1330b1126],

1	Successful	JJ	O	successful	amod	2	SENT_66	[p4l1375t1047r1814b1127],
2	results	NNS	O	result	nsubjpass	13	SENT_66	[p4l1856t1048r2132b1127],
3	With	IN	O	with	_	0	SENT_66	[p4l6t1176r196b1255],
4	the	DT	O	the	det	5	SENT_66	[p4l233t1176r362b1254],
5	use	NN	O	use	prep_with	13	SENT_66	[p4l401t1202r539b1255],
6	of	IN	O	of	_	0	SENT_66	[p4l579t1175r679b1254],
7	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_66	[p4l696t1181r956b1259],
8	and	CC	O	and	_	0	SENT_66	[p4l982t1175r1138b1254],
9	KIT	NN	O	kit	nn	10	SENT_66	[p4l1175t1181r1334b1257],
10	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_66	[p4l1367t1175r1781b1254],
11	are	VBP	O	be	auxpass	13	SENT_66	[p4l1821t1202r1946b1254],
12	primarily	RB	O	primarily	advmod	13	SENT_66	[p4l1983t1176r2134b1276, p4l11t1304r280b1404],
13	related	VBN	O	relate	_	0	SENT_66	[p4l314t1303r600b1382],
14	to	TO	O	to	_	0	SENT_66	[p4l638t1320r717b1382],
15	gene	NN	O	gene	nn	16	SENT_66	[p4l757t1329r956b1404],
16	mutations	NNS	O	mutation	prep_to	13	SENT_66	[p4l994t1304r1425b1383],
17	involving	VBG	O	involve	_	0	SENT_66	[p4l1465t1304r1856b1404],
18	exons	NNS	O	exon	prep_involving	16	SENT_66	[p4l1892t1329r2132b1382],
19	encoding	VBG	O	encode	partmod	18	SENT_66	[p4l11t1432r407b1532],
20	for	IN	O	for	_	0	SENT_66	[p4l454t1431r577b1510],
21	juxtamembrane	NN	O	juxtamembrane	nn	23	SENT_66	[p4l611t1432r1290b1532],
22	protein	NN	O	protein	nn	23	SENT_66	[p4l1340t1432r1647b1532],
23	domains	NNS	O	domain	prep_for	19	SENT_66	[p4l1698t1431r2132b1527],
24	,3	CD	NUMBER	,3	tmod	19	SENT_66	[p4l1698t1431r2132b1527],
25	possibly	RB	O	possibly	advmod	26	SENT_66	[p4l9t1560r361b1660],
26	leading	VBG	O	lead	xcomp	19	SENT_66	[p4l392t1559r707b1660],
27	to	TO	O	to	_	0	SENT_66	[p4l740t1576r819b1638],
28	cytoplasmic	JJ	O	cytoplasmic	amod	29	SENT_66	[p4l857t1559r1360b1660],
29	internalization	NN	O	internalization	prep_to	26	SENT_66	[p4l1394t1559r2016b1638],
30	of	IN	O	of	_	0	SENT_66	[p4l2053t1559r2154b1638],
31	mutated	VBN	O	mutate	amod	33	SENT_66	[p4l11t1688r358b1767],
32	tyrosine	NN	O	tyrosine	nn	33	SENT_66	[p4l379t1688r710b1788],
33	kinase	NN	O	kinase	prep_of	29	SENT_66	[p4l731t1688r1022b1767],
34	.	.	O	.	_	0	SENT_66	[p4l731t1688r1022b1767],

1	If	IN	O	if	mark	5	SENT_67	[p4l1047t1687r1127b1765],
2	this	DT	O	this	det	3	SENT_67	[p4l1130t1687r1281b1766],
3	theory	NN	O	theory	nsubjpass	5	SENT_67	[p4l1304t1687r1570b1788],
4	is	VBZ	O	be	auxpass	5	SENT_67	[p4l1585t1688r1650b1766],
5	conﬁrmed	VBN	O	conﬁrmed	advcl	9	SENT_67	[p4l1673t1687r2130b1783],
6	,	,	O	,	_	0	SENT_67	[p4l1673t1687r2130b1783],
7	one	PRP	NUMBER	one	nsubj	9	SENT_67	[p4l11t1841r163b1894],
8	can	MD	O	can	aux	9	SENT_67	[p4l188t1841r332b1894],
9	expect	VB	O	expect	_	0	SENT_67	[p4l357t1832r628b1916],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_67	[p4l647t1816r1122b1916],
11	beneﬁts	NNS	O	beneﬁts	dobj	9	SENT_67	[p4l1146t1815r1478b1894],
12	from	IN	O	from	_	0	SENT_67	[p4l1504t1815r1712b1894],
13	the	DT	O	the	det	14	SENT_67	[p4l1736t1816r1865b1894],
14	use	NN	O	use	prep_from	9	SENT_67	[p4l1889t1842r2028b1895],
15	of	IN	O	of	_	0	SENT_67	[p4l2053t1815r2153b1894],
16	antibodies	NNS	O	antibody	prep_of	14	SENT_67	[p4l10t1943r450b2022],
17	against	IN	O	against	_	0	SENT_67	[p4l487t1944r797b2044],
18	EGFR	NN	ORGANIZATION	egfr	prep_against	16	SENT_67	[p4l827t1949r1086b2027],
19	rather	RB	O	rather	_	0	SENT_67	[p4l1112t1944r1367b2022],
20	than	IN	O	than	_	0	SENT_67	[p4l1400t1943r1588b2022],
21	small	JJ	O	small	amod	22	SENT_67	[p4l1626t1944r1854b2022],
22	molecules	NNS	O	molecule	conj_negcc	14	SENT_67	[p4l1890t1944r2134b2022, p4l11t2071r221b2151],
23	in	IN	O	in	_	0	SENT_67	[p4l247t2072r328b2149],
24	lung	NN	O	lung	nn	25	SENT_67	[p4l352t2072r546b2172],
25	cancer	NN	O	cancer	prep_in	22	SENT_67	[p4l567t2097r842b2150],
26	expressing	VBG	O	express	partmod	25	SENT_67	[p4l865t2072r1322b2172],
27	nonmutated	JJ	O	nonmutated	amod	28	SENT_67	[p4l1343t2071r1864b2151],
28	EGFR	NN	ORGANIZATION	egfr	dobj	26	SENT_67	[p4l1887t2077r2145b2155],
29	at	IN	O	at	_	0	SENT_67	[p4l10t2216r89b2278],
30	the	DT	O	the	det	32	SENT_67	[p4l109t2200r238b2278],
31	membrane	NN	O	membrane	nn	32	SENT_67	[p4l264t2200r722b2278],
32	level	NN	O	level	prep_at	26	SENT_67	[p4l746t2199r957b2279],
33	.	.	O	.	_	0	SENT_67	[p4l746t2199r957b2279],

1	Giulio	NNP	PERSON	Giulio	nn	2	SENT_68	[p4l13t2330r273b2410],
2	Rossi	NNP	PERSON	Rossi	_	0	SENT_68	[p4l314t2338r565b2424],
3	,	,	O	,	_	0	SENT_68	[p4l314t2338r565b2424],
4	M.D.	NNP	PERSON	M.D.	nn	8	SENT_68	[p4l609t2338r815b2410],
5	Alessandro	NNP	PERSON	Alessandro	nn	8	SENT_68	[p4l9t2458r500b2538],
6	Marchioni	NNP	PERSON	Marchioni	nn	8	SENT_68	[p4l541t2458r1005b2552],
7	,	,	O	,	_	0	SENT_68	[p4l541t2458r1005b2552],
8	M.D.	NNP	O	M.D.	appos	2	SENT_68	[p4l1050t2466r1255b2538],

1	University	NNP	O	University	nn	2	SENT_69	[p4l15t2615r342b2689],
2	ofModena	NNP	O	ofModena	_	0	SENT_69	[p4l364t2609r719b2671],
3	and	CC	O	and	_	0	SENT_69	[p4l746t2610r862b2670],
4	Reggio	NNP	ORGANIZATION	Reggio	nn	7	SENT_69	[p4l895t2615r1113b2690],
5	Emilia	NNP	ORGANIZATION	Emilia	nn	7	SENT_69	[p4l1144t2610r1340b2670],
6	41100	CD	NUMBER	41100	num	7	SENT_69	[p4l9t2698r207b2755],
7	Modena	NNP	LOCATION	Modena	conj_and	2	SENT_69	[p4l236t2694r520b2765],
8	,	,	O	,	_	0	SENT_69	[p4l236t2694r520b2765],
9	Italy	NNP	LOCATION	Italy	nn	10	SENT_69	[p4l553t2694r683b2773],
10	rossi	NNS	O	rossus	appos	2	SENT_69	[p4l14t2778r740b2858],
11	.	.	O	.	_	0	SENT_69	[p4l14t2778r740b2858],

1	giu	NN	O	giu	_	0	SENT_70	[p4l14t2778r740b2858],
2	|	CD	NUMBER	|	num	3	SENT_70	[p4l14t2778r740b2858],
3	io@unimo.it	NN	O	io@unimo.it	dep	1	SENT_70	[p4l14t2778r740b2858],

1	Lucia	NNP	PERSON	Lucia	nn	2	SENT_71	[p4l19t2924r238b2996],
2	Longo	NNP	PERSON	Longo	_	0	SENT_71	[p4l281t2924r569b3022],
3	,	,	O	,	_	0	SENT_71	[p4l281t2924r569b3022],
4	M.D.	NNP	O	M.D.	appos	2	SENT_71	[p4l614t2924r820b2996],

1	Hospital	NN	O	hospital	_	0	SENT_72	[p4l16t3068r289b3147],
2	of	IN	O	of	_	0	SENT_72	[p4l317t3067r388b3129],
3	Faenza	NNP	PERSON	Faenza	prep_of	1	SENT_72	[p4l407t3073r626b3129],
4	48018	CD	NUMBER	48018	num	3	SENT_72	[p4l9t3156r205b3213],
5	Faenza	NNP	PERSON	Faenza	dep	1	SENT_72	[p4l236t3157r474b3223],
6	,	,	O	,	_	0	SENT_72	[p4l236t3157r474b3223],
7	Italy	NNP	LOCATION	Italy	appos	5	SENT_72	[p4l507t3152r638b3231],
8	1	CD	NUMBER	1	num	7	SENT_72	[p4l12t3262r60b3313],
9	.	.	O	.	_	0	SENT_72	[p4l12t3262r60b3313],

1	Hirota	NNP	ORGANIZATION	Hirota	nn	2	SENT_73	[p4l138t3255r345b3313],
2	S	NNP	ORGANIZATION	S	_	0	SENT_73	[p4l368t3259r420b3326],
3	,	,	O	,	_	0	SENT_73	[p4l368t3259r420b3326],
4	Isozaki	NNP	PERSON	Isozaki	nn	5	SENT_73	[p4l446t3255r675b3314],
5	K	NNP	PERSON	K	appos	2	SENT_73	[p4l696t3260r762b3326],
6	,	,	O	,	_	0	SENT_73	[p4l696t3260r762b3326],
7	Moriyama	NNP	PERSON	Moriyama	nn	8	SENT_73	[p4l786t3255r1110b3330],
8	Y	NN	PERSON	y	appos	2	SENT_73	[p4l1129t3260r1180b3326],
9	,	,	O	,	_	0	SENT_73	[p4l1129t3260r1180b3326],
10	et	FW	O	et	nn	11	SENT_73	[p4l1207t3267r1265b3313],
11	al.	FW	O	al.	appos	2	SENT_73	[p4l1284t3255r1354b3313],
12	.	.	O	.	_	0	SENT_73	[p4l1284t3255r1354b3313],

1	Gain	NN	O	gain	nn	2	SENT_74	[p4l1381t3254r1923b3314],
2	—	NN	O	—	_	0	SENT_74	[p4l1381t3254r1923b3314],
3	of	IN	O	of	_	0	SENT_74	[p4l1381t3254r1923b3314],
4	—	CD	NUMBER	—	num	6	SENT_74	[p4l1381t3254r1923b3314],
5	ﬁ1nction	NN	O	ﬁ1nction	nn	6	SENT_74	[p4l1381t3254r1923b3314],
6	mutations	NNS	O	mutation	prep_of	2	SENT_74	[p4l1946t3267r2134b3314, p4l10t3339r166b3397],
7	of	IN	O	of	_	0	SENT_74	[p4l200t3338r276b3397],
8	c	NN	O	c	prep_of	6	SENT_74	[p4l294t3339r438b3398],
9	—	CD	NUMBER	—	num	10	SENT_74	[p4l294t3339r438b3398],
10	l	NN	O	l	tmod	6	SENT_74	[p4l294t3339r438b3398],
11	<	JJR	O	<	dep	2	SENT_74	[p4l294t3339r438b3398],
12	it	PRP	O	it	dep	11	SENT_74	[p4l294t3339r438b3398],
13	in	IN	O	in	_	0	SENT_74	[p4l465t3339r527b3396],
14	human	JJ	O	human	amod	17	SENT_74	[p4l558t3339r784b3398],
15	gastrointestinal	JJ	O	gastrointestinal	amod	17	SENT_74	[p4l816t3339r1312b3414],
16	stromal	JJ	O	stromal	amod	17	SENT_74	[p4l1345t3339r1587b3397],
17	tumors	NNS	O	tumor	prep_in	12	SENT_74	[p4l1619t3351r1864b3398],
18	.	.	O	.	_	0	SENT_74	[p4l1619t3351r1864b3398],

1	Science	NN	O	science	_	0	SENT_75	[p4l1902t3339r2136b3397],
2	1998	CD	DATE	1998	num	1	SENT_75	[p4l12t3440r570b3507],
3	;	:	O	;	_	0	SENT_75	[p4l12t3440r570b3507],
4	279:577	CD	NUMBER	279:577	number	5	SENT_75	[p4l12t3440r570b3507],
5	—	CD	NUMBER	—	dep	1	SENT_75	[p4l12t3440r570b3507],
6	80	CD	NUMBER	80	dep	5	SENT_75	[p4l12t3440r570b3507],
7	.	.	O	.	_	0	SENT_75	[p4l12t3440r570b3507],

1	2	LS	NUMBER	2	_	0	SENT_76	[p4l8t3527r60b3578],
2	.	.	O	.	_	0	SENT_76	[p4l8t3527r60b3578],

1	Gibson	NNP	PERSON	Gibson	nn	2	SENT_77	[p4l139t3520r371b3578],
2	PC	NNP	O	PC	_	0	SENT_77	[p4l394t3524r498b3591],
3	,	,	O	,	_	0	SENT_77	[p4l394t3524r498b3591],
4	Cooper	NNP	PERSON	Cooper	nn	8	SENT_77	[p4l526t3524r760b3595],
5	K.	NNP	PERSON	K.	nn	8	SENT_77	[p4l781t3525r846b3580],
6	CD117	NNP	PERSON	CD117	nn	8	SENT_77	[p4l874t3524r1092b3578],
7	(	NNP	O	(	nn	8	SENT_77	[p4l1121t3524r1304b3588],
8	KIT	NNP	O	KIT	appos	2	SENT_77	[p4l1121t3524r1304b3588],
9	)	CD	NUMBER	)	num	8	SENT_77	[p4l1121t3524r1304b3588],
10	:	:	O	:	_	0	SENT_77	[p4l1121t3524r1304b3588],
11	a	DT	O	a	det	13	SENT_77	[p4l1331t3539r1365b3578],
12	diverse	JJ	O	diverse	amod	13	SENT_77	[p4l1388t3520r1607b3579],
13	protein	NN	O	protein	dep	2	SENT_77	[p4l1630t3520r1861b3595],
14	with	IN	O	with	_	0	SENT_77	[p4l1881t3520r2024b3579],
15	selective	JJ	O	selective	amod	16	SENT_77	[p4l2048t3539r2136b3578, p4l9t3606r206b3665],
16	applications	NNS	O	application	prep_with	13	SENT_77	[p4l230t3606r617b3681],
17	in	IN	O	in	_	0	SENT_77	[p4l643t3606r704b3663],
18	surgical	JJ	O	surgical	amod	19	SENT_77	[p4l729t3606r978b3681],
19	pathology	NN	O	pathology	prep_in	16	SENT_77	[p4l1002t3606r1329b3681],
20	.	.	O	.	_	0	SENT_77	[p4l1002t3606r1329b3681],

1	Adv	NNP	O	Adv	nn	3	SENT_78	[p4l1355t3606r1479b3665],
2	Anat	NNP	O	Anat	nn	3	SENT_78	[p4l1497t3611r1651b3664],
3	Pathol	NNP	O	Pathol	_	0	SENT_78	[p4l1670t3606r1873b3664],
4	2002	CD	DATE	2002	num	3	SENT_78	[p4l1897t3610r2132b3677],
5	;	:	O	;	_	0	SENT_78	[p4l1897t3610r2132b3677],
6	9	CD	NUMBER	9	num	8	SENT_78	[p4l1897t3610r2132b3677],
7	:	:	O	:	_	0	SENT_78	[p4l1897t3610r2132b3677],
8	65-9	CD	NUMBER	65-9	dep	3	SENT_78	[p4l10t3707r169b3761],
9	.	.	O	.	_	0	SENT_78	[p4l10t3707r169b3761],

1	3	LS	NUMBER	3	_	0	SENT_79	[p5l10t27r60b78],
2	.	.	O	.	_	0	SENT_79	[p5l10t27r60b78],

1	Singer	NNP	O	Singer	nn	2	SENT_80	[p5l140t20r344b95],
2	S	NNP	O	S	_	0	SENT_80	[p5l361t24r413b91],
3	,	,	O	,	_	0	SENT_80	[p5l361t24r413b91],
4	Rubin	NNP	PERSON	Rubin	nn	5	SENT_80	[p5l433t20r628b82],
5	BP	NNP	O	BP	appos	2	SENT_80	[p5l643t25r738b91],
6	,	,	O	,	_	0	SENT_80	[p5l643t25r738b91],
7	Lux	FW	O	lux	dep	2	SENT_80	[p5l758t25r874b79],
8	ML	NN	O	ml	dep	2	SENT_80	[p5l887t25r1009b91],
9	,	,	O	,	_	0	SENT_80	[p5l887t25r1009b91],
10	et	FW	O	et	nn	11	SENT_80	[p5l1031t32r1089b78],
11	al.	FW	O	al.	appos	8	SENT_80	[p5l1103t20r1173b78],
12	.	.	O	.	_	0	SENT_80	[p5l1103t20r1173b78],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_81	[p5l1194t20r1537b95],
2	value	NN	O	value	_	0	SENT_81	[p5l1550t20r1714b79],
3	of	IN	O	of	_	0	SENT_81	[p5l1733t19r1808b78],
4	KIT	NN	O	kit	nn	5	SENT_81	[p5l1812t24r1931b80],
5	muta	NN	O	muta	prep_of	2	SENT_81	[p5l1946t32r2134b79],
6	—	CD	NUMBER	—	num	8	SENT_81	[p5l1946t32r2134b79],
7	tion	NN	O	tion	nn	8	SENT_81	[p5l10t106r135b164],
8	type	NN	O	type	dep	2	SENT_81	[p5l155t118r301b181],
9	,	,	O	,	_	0	SENT_81	[p5l155t118r301b181],
10	mitotic	JJ	O	mitotic	amod	11	SENT_81	[p5l325t106r551b164],
11	activity	NN	O	activity	appos	8	SENT_81	[p5l570t106r800b181],
12	,	,	O	,	_	0	SENT_81	[p5l570t106r800b181],
13	and	CC	O	and	_	0	SENT_81	[p5l824t106r941b164],
14	histologic	JJ	O	histologic	amod	15	SENT_81	[p5l961t106r1276b181],
15	subtype	NN	O	subtype	dep	2	SENT_81	[p5l1297t106r1539b181],
16	in	IN	O	in	_	0	SENT_81	[p5l1559t106r1620b163],
17	gastrointestinal	JJ	O	gastrointestinal	amod	19	SENT_81	[p5l1640t106r2136b181],
18	stromal	JJ	O	stromal	amod	19	SENT_81	[p5l11t189r253b247],
19	tumors	NNS	O	tumor	prep_in	15	SENT_81	[p5l272t201r517b248],
20	.	.	O	.	_	0	SENT_81	[p5l272t201r517b248],

1	J	NNP	O	J	nn	3	SENT_82	[p5l532t194r561b257],
2	Clin	NNP	O	Clin	nn	3	SENT_82	[p5l577t189r708b247],
3	Oncol	NNP	O	Oncol	_	0	SENT_82	[p5l726t189r917b247],
4	2002	CD	DATE	2002	num	3	SENT_82	[p5l936t193r1536b260],
5	;	:	O	;	_	0	SENT_82	[p5l936t193r1536b260],
6	20:3898	CD	NUMBER	20:3898	number	7	SENT_82	[p5l936t193r1536b260],
7	-905	CD	NUMBER	-905	dep	3	SENT_82	[p5l936t193r1536b260],
8	.	.	O	.	_	0	SENT_82	[p5l936t193r1536b260],

1	TH	NN	O	th	nn	4	SENT_83	[p5l9t483r107b531],
2	E	NN	O	e	nn	4	SENT_83	[p5l126t483r159b531],
3	AUTH	NN	O	auth	nn	4	SENT_83	[p5l188t483r394b532],
4	ons	NNS	O	on	_	0	SENT_83	[p5l410t482r558b532],
5	REPLY	NNP	O	REPLY	dep	4	SENT_83	[p5l593t483r837b532],
6	:	:	O	:	_	0	SENT_83	[p5l593t483r837b532],
7	We	PRP	O	we	nsubj	8	SENT_83	[p5l863t462r995b532],
8	agree	VBP	O	agree	dep	4	SENT_83	[p5l1014t480r1234b555],
9	with	IN	O	with	_	0	SENT_83	[p5l1250t454r1435b533],
10	Dr.	NNP	O	Dr.	nn	11	SENT_83	[p5l1452t460r1575b533],
11	Sorscher	NNP	PERSON	Sorscher	prep_with	8	SENT_83	[p5l1602t454r1962b533],
12	that	WDT	O	that	dobj	16	SENT_83	[p5l1978t454r2141b532],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_83	[p5l9t589r222b662],
14	mutations	NNS	O	mutation	nsubj	16	SENT_83	[p5l246t583r676b661],
15	are	VBP	O	be	cop	16	SENT_83	[p5l708t608r834b660],
16	likely	JJ	O	likely	rcmod	11	SENT_83	[p5l864t582r1090b682],
17	to	TO	O	to	aux	18	SENT_83	[p5l1117t599r1196b661],
18	identify	VB	O	identify	xcomp	16	SENT_83	[p5l1227t581r1549b682],
19	a	DT	O	a	det	22	SENT_83	[p5l1575t608r1619b660],
20	discrete	JJ	O	discrete	amod	22	SENT_83	[p5l1648t582r1975b661],
21	genetic	JJ	O	genetic	amod	22	SENT_83	[p5l2005t608r2134b683, p5l11t711r210b788],
22	subgroup	NN	O	subgroup	dobj	18	SENT_83	[p5l231t710r628b811],
23	of	IN	O	of	_	0	SENT_83	[p5l649t709r749b789],
24	non	JJ	O	non	amod	30	SENT_83	[p5l750t710r1371b789],
25	—	JJ	O	—	amod	30	SENT_83	[p5l750t710r1371b789],
26	small	JJ	O	small	amod	30	SENT_83	[p5l750t710r1371b789],
27	—	NN	O	—	nn	30	SENT_83	[p5l750t710r1371b789],
28	cell	NN	O	cell	nn	30	SENT_83	[p5l750t710r1371b789],
29	lung	NN	O	lung	nn	30	SENT_83	[p5l1389t710r1580b811],
30	cancers	NNS	O	cancer	prep_of	22	SENT_83	[p5l1597t736r1930b789],
31	.	.	O	.	_	0	SENT_83	[p5l1597t736r1930b789],

1	This	DT	O	this	det	2	SENT_84	[p5l1951t710r2134b788],
2	subgroup	NN	O	subgroup	nsubj	5	SENT_84	[p5l12t838r415b939],
3	is	VBZ	O	be	cop	5	SENT_84	[p5l442t839r507b916],
4	uniquely	RB	O	uniquely	advmod	5	SENT_84	[p5l536t838r903b938],
5	sensitive	JJ	O	sensitive	_	0	SENT_84	[p5l926t839r1285b917],
6	to	TO	O	to	_	0	SENT_84	[p5l1313t855r1391b917],
7	geﬁtinib	NN	O	geﬁtinib	prep_to	5	SENT_84	[p5l1419t837r1798b939],
8	,	,	O	,	_	0	SENT_84	[p5l1419t837r1798b939],
9	but	CC	O	but	_	0	SENT_84	[p5l1831t838r1972b917],
10	our	PRP$	O	we	poss	11	SENT_84	[p5l1994t864r2138b917],
11	study	NN	O	study	nsubjpass	14	SENT_84	[p5l12t966r238b1066],
12	was	VBD	O	be	auxpass	14	SENT_84	[p5l251t992r411b1045],
13	not	RB	O	not	neg	14	SENT_84	[p5l435t983r579b1045],
14	designed	VBN	O	design	conj_but	5	SENT_84	[p5l597t966r976b1067],
15	to	TO	O	to	aux	16	SENT_84	[p5l998t983r1077b1045],
16	test	VB	O	test	xcomp	14	SENT_84	[p5l1101t983r1252b1044],
17	for	IN	O	for	_	0	SENT_84	[p5l1269t965r1392b1045],
18	altered	JJ	O	altered	amod	19	SENT_84	[p5l1410t966r1696b1045],
19	sensitivity	NN	O	sensitivity	prep_for	16	SENT_84	[p5l1720t967r2140b1066],
20	to	TO	O	to	_	0	SENT_84	[p5l11t1111r90b1173],
21	other	JJ	O	other	amod	23	SENT_84	[p5l116t1094r340b1173],
22	chemotherapeutic	JJ	O	chemotherapeutic	amod	23	SENT_84	[p5l361t1094r1126b1194],
23	agents	NNS	O	agent	prep_to	16	SENT_84	[p5l1149t1111r1447b1195],
24	.	.	O	.	_	0	SENT_84	[p5l1149t1111r1447b1195],

1	Geﬁtinib	NNP	O	Geﬁtinib	nsubjpass	4	SENT_85	[p5l1477t1093r1853b1173],
2	is	VBZ	O	be	auxpass	4	SENT_85	[p5l1878t1095r1943b1172],
3	currently	RB	DATE	currently	advmod	4	SENT_85	[p5l1969t1120r2134b1173, p5l11t1222r247b1321],
4	approved	VBN	O	approve	_	0	SENT_85	[p5l263t1222r646b1321],
5	as	IN	O	as	_	0	SENT_85	[p5l665t1248r748b1300],
6	third-line	JJ	O	third-line	amod	7	SENT_85	[p5l772t1222r1159b1300],
7	therapy	NN	O	therapy	prep_as	4	SENT_85	[p5l1180t1222r1491b1321],
8	in	IN	O	in	_	0	SENT_85	[p5l1506t1223r1586b1299],
9	patients	NNS	O	patient	prep_in	7	SENT_85	[p5l1605t1223r1932b1321],
10	With	IN	O	with	_	0	SENT_85	[p5l1950t1222r2136b1301],
11	non	JJ	O	non	amod	17	SENT_85	[p5l11t1350r642b1429],
12	—	JJ	O	—	amod	17	SENT_85	[p5l11t1350r642b1429],
13	small	JJ	O	small	amod	17	SENT_85	[p5l11t1350r642b1429],
14	—	NN	O	—	nn	17	SENT_85	[p5l11t1350r642b1429],
15	cell	NN	O	cell	nn	17	SENT_85	[p5l11t1350r642b1429],
16	lung	NN	O	lung	nn	17	SENT_85	[p5l664t1350r858b1451],
17	cancer	NN	O	cancer	prep_with	9	SENT_85	[p5l878t1376r1176b1446],
18	;	:	O	;	_	0	SENT_85	[p5l878t1376r1176b1446],
19	most	JJS	O	most	nsubj	33	SENT_85	[p5l1203t1367r1420b1429],
20	of	IN	O	of	_	0	SENT_85	[p5l1438t1349r1539b1429],
21	the	DT	O	the	det	22	SENT_85	[p5l1544t1350r1673b1428],
22	patients	NNS	O	patient	prep_of	19	SENT_85	[p5l1695t1351r2029b1450],
23	in	IN	O	in	_	0	SENT_85	[p5l2054t1351r2135b1428],
24	our	PRP$	O	we	poss	25	SENT_85	[p5l11t1504r153b1557],
25	study	NN	O	study	prep_in	22	SENT_85	[p5l171t1478r393b1577],
26	had	VBD	O	have	aux	28	SENT_85	[p5l408t1478r561b1556],
27	previously	RB	DATE	previously	advmod	28	SENT_85	[p5l579t1478r1003b1577],
28	received	VBN	O	receive	parataxis	4	SENT_85	[p5l1019t1478r1353b1557],
29	chemotherapy	NN	O	chemotherapy	dobj	28	SENT_85	[p5l1373t1478r1968b1577],
30	and	CC	O	and	_	0	SENT_85	[p5l1982t1478r2136b1556],
31	then	RB	O	then	advmod	33	SENT_85	[p5l11t1606r195b1685],
32	subsequently	RB	O	subsequently	advmod	33	SENT_85	[p5l216t1606r761b1706],
33	received	VBN	O	receive	conj_and	28	SENT_85	[p5l776t1606r1109b1685],
34	geﬁtinib	NN	O	geﬁtinib	dep	33	SENT_85	[p5l1129t1605r1475b1707],
35	alone	RB	O	alone	advmod	34	SENT_85	[p5l1496t1606r1743b1685],
36	.	.	O	.	_	0	SENT_85	[p5l1496t1606r1743b1685],

1	Ongoing	JJ	O	ongoing	amod	2	SENT_86	[p5l1768t1607r2140b1707],
2	analyses	NNS	O	analysis	nsubj	22	SENT_86	[p5l10t1734r358b1834],
3	of	IN	O	of	_	0	SENT_86	[p5l403t1733r504b1813],
4	specimens	NNS	O	specimen	prep_of	2	SENT_86	[p5l529t1735r973b1834],
5	from	IN	O	from	_	0	SENT_86	[p5l1017t1733r1224b1813],
6	larger	JJR	O	larger	amod	8	SENT_86	[p5l1265t1734r1514b1835],
7	clinical	JJ	O	clinical	amod	8	SENT_86	[p5l1554t1734r1855b1812],
8	trials	NNS	O	trial	prep_from	4	SENT_86	[p5l1897t1734r2130b1830],
9	,	,	O	,	_	0	SENT_86	[p5l1897t1734r2130b1830],
10	which	WDT	O	which	nsubj	11	SENT_86	[p5l6t1862r263b1941],
11	compared	VBD	O	compare	rcmod	2	SENT_86	[p5l286t1862r702b1961],
12	chemotherapy	NN	O	chemotherapy	dobj	11	SENT_86	[p5l724t1862r1322b1961],
13	with	IN	O	with	_	0	SENT_86	[p5l1334t1862r1521b1941],
14	chemotherapy	NN	O	chemotherapy	prep_with	11	SENT_86	[p5l1543t1862r2140b1961],
15	plus	CC	O	plus	prep	14	SENT_86	[p5l9t1990r186b2089],
16	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_86	[p5l217t1996r477b2073],
17	tyrosine	NN	O	tyrosine	nn	19	SENT_86	[p5l497t1991r832b2089],
18	kinase	NN	O	kinase	nn	19	SENT_86	[p5l862t1990r1133b2069],
19	inhibitors	NNS	O	inhibitor	dep	15	SENT_86	[p5l1163t1990r1602b2085],
20	,	,	O	,	_	0	SENT_86	[p5l1163t1990r1602b2085],
21	should	MD	O	should	aux	22	SENT_86	[p5l1640t1990r1927b2069],
22	provide	VB	O	provide	_	0	SENT_86	[p5l1956t2016r2134b2089, p5l6t2118r174b2197],
23	insight	NN	O	insight	dobj	22	SENT_86	[p5l195t2118r489b2219],
24	into	IN	O	into	_	0	SENT_86	[p5l505t2119r667b2197],
25	any	DT	O	any	det	27	SENT_86	[p5l690t2144r835b2218],
26	differential	JJ	O	differential	amod	27	SENT_86	[p5l853t2117r1306b2197],
27	response	NN	O	response	prep_into	22	SENT_86	[p5l1327t2144r1699b2218],
28	to	TO	O	to	_	0	SENT_86	[p5l1721t2135r1799b2197],
29	chemotherapy	NN	O	chemotherapy	prep_to	27	SENT_86	[p5l1822t2118r2135b2197, p5l11t2246r322b2346],
30	by	IN	O	by	_	0	SENT_86	[p5l343t2246r440b2346],
31	tumors	NNS	O	tumor	prep_by	22	SENT_86	[p5l460t2263r762b2325],
32	harboring	VBG	O	harbor	partmod	31	SENT_86	[p5l789t2246r1216b2347],
33	EGFR	NN	ORGANIZATION	egfr	nn	34	SENT_86	[p5l1235t2252r1448b2326],
34	mutations	NNS	O	mutation	dobj	32	SENT_86	[p5l1466t2247r1922b2325],
35	.	.	O	.	_	0	SENT_86	[p5l1466t2247r1922b2325],

1	In	IN	O	in	_	0	SENT_87	[p5l140t2382r228b2452],
2	response	NN	O	response	prep_in	17	SENT_87	[p5l257t2400r638b2475],
3	to	TO	O	to	_	0	SENT_87	[p5l668t2391r748b2453],
4	Rich	NNP	PERSON	Rich	prep_to	2	SENT_87	[p5l777t2374r971b2458],
5	et	FW	O	et	nn	6	SENT_87	[p5l1001t2391r1078b2453],
6	al.	FW	O	al.	dep	4	SENT_87	[p5l1102t2375r1226b2470],
7	,	,	O	,	_	0	SENT_87	[p5l1102t2375r1226b2470],
8	the	DT	O	the	det	10	SENT_87	[p5l1261t2375r1391b2453],
9	frequent	JJ	O	frequent	amod	10	SENT_87	[p5l1421t2374r1784b2475],
10	ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	17	SENT_87	[p5l1808t2374r2145b2475, p5l12t2503r271b2581],
11	of	IN	O	of	_	0	SENT_87	[p5l296t2502r397b2581],
12	EGFR	NN	ORGANIZATION	egfr	prep_of	10	SENT_87	[p5l401t2509r615b2582],
13	in	IN	O	in	_	0	SENT_87	[p5l632t2503r714b2580],
14	glioblastomas	NNS	O	glioblastoma	prep_in	12	SENT_87	[p5l738t2502r1336b2603],
15	is	VBZ	O	be	auxpass	17	SENT_87	[p5l1362t2503r1427b2581],
16	Well	UH	O	well	attr	17	SENT_87	[p5l1449t2502r1624b2582],
17	recognized	VBN	O	recognize	_	0	SENT_87	[p5l1649t2502r2141b2603],
18	,	,	O	,	_	0	SENT_87	[p5l1649t2502r2141b2603],
19	as	IN	O	as	mark	22	SENT_87	[p5l11t2657r95b2709],
20	is	VBZ	O	be	cop	22	SENT_87	[p5l127t2631r192b2709],
21	the	DT	O	the	det	22	SENT_87	[p5l225t2631r354b2709],
22	presence	NN	O	presence	advcl	17	SENT_87	[p5l383t2656r758b2731],
23	of	IN	O	of	prep	22	SENT_87	[p5l789t2630r890b2709],
24	in	IN	O	in	pcomp	23	SENT_87	[p5l900t2630r1269b2709],
25	—	NN	O	—	nn	27	SENT_87	[p5l900t2630r1269b2709],
26	frame	NN	O	frame	nn	27	SENT_87	[p5l900t2630r1269b2709],
27	deletions	NNS	O	deletion	pobj	24	SENT_87	[p5l1300t2630r1684b2709],
28	Within	IN	O	within	_	0	SENT_87	[p5l1711t2631r1987b2710],
29	the	DT	O	the	det	31	SENT_87	[p5l2017t2631r2147b2709],
30	extracellular	JJ	O	extracellular	amod	31	SENT_87	[p5l12t2758r535b2838],
31	domain	NN	O	domain	prep_within	50	SENT_87	[p5l558t2758r907b2854],
32	,	,	O	,	_	0	SENT_87	[p5l558t2758r907b2854],
33	such	JJ	O	such	_	0	SENT_87	[p5l939t2759r1134b2838],
34	as	IN	O	as	_	0	SENT_87	[p5l1158t2785r1243b2837],
35	the	DT	O	the	det	37	SENT_87	[p5l1271t2758r1400b2837],
36	V111	NN	O	v111	nn	37	SENT_87	[p5l1421t2766r1564b2838],
37	mutation	NN	O	mutation	prep_such_as	31	SENT_87	[p5l1588t2759r2003b2854],
38	,	,	O	,	_	0	SENT_87	[p5l1588t2759r2003b2854],
39	resulting	VBG	O	result	csubj	50	SENT_87	[p5l2034t2785r2145b2837, p5l13t2887r308b2988],
40	in	IN	O	in	_	0	SENT_87	[p5l343t2888r425b2965],
41	constitutive	JJ	O	constitutive	amod	42	SENT_87	[p5l464t2888r954b2967],
42	activation	NN	O	activation	prep_in	39	SENT_87	[p5l992t2888r1401b2967],
43	of	IN	O	of	_	0	SENT_87	[p5l1441t2887r1542b2966],
44	the	DT	O	the	det	47	SENT_87	[p5l1563t2888r1692b2966],
45	receptor	NN	O	receptor	nn	47	SENT_87	[p5l1731t2893r2147b2988],
46	.1	NN	NUMBER	.1	nn	47	SENT_87	[p5l1731t2893r2147b2988],
47	Geﬁtinib	NN	O	geﬁtinib	prep_of	42	SENT_87	[p5l12t3015r382b3094],
48	did	VBD	O	do	aux	50	SENT_87	[p5l403t3016r535b3094],
49	not	RB	O	not	neg	50	SENT_87	[p5l554t3032r696b3094],
50	induce	VB	O	induce	csubj	61	SENT_87	[p5l710t3015r989b3095],
51	dramatic	JJ	O	dramatic	amod	52	SENT_87	[p5l1009t3015r1376b3094],
52	responses	NNS	O	response	dobj	50	SENT_87	[p5l1396t3041r1810b3116],
53	in	IN	O	in	_	0	SENT_87	[p5l1831t3016r1911b3093],
54	brain	NN	O	brain	nn	55	SENT_87	[p5l1932t3016r2148b3094],
55	tumors	NNS	O	tumor	prep_in	52	SENT_87	[p5l12t3160r315b3223],
56	despite	IN	O	despite	_	0	SENT_87	[p5l358t3143r659b3244],
57	these	DT	O	these	det	60	SENT_87	[p5l700t3144r920b3222],
58	common	JJ	O	common	amod	60	SENT_87	[p5l961t3169r1343b3222],
59	EGFR	NN	ORGANIZATION	egfr	nn	60	SENT_87	[p5l1381t3150r1594b3223],
60	alterations	NNS	O	alteration	prep_despite	50	SENT_87	[p5l1628t3143r2146b3239],
61	}	VBP	O	}	rcmod	22	SENT_87	[p5l1628t3143r2146b3239],
62	Which	WDT	O	which	nsubj	63	SENT_87	[p5l7t3272r269b3351],
63	suggests	VBZ	O	suggest	ccomp	61	SENT_87	[p5l304t3288r668b3372],
64	the	DT	O	the	det	65	SENT_87	[p5l705t3272r834b3350],
65	importance	NN	O	importance	dobj	63	SENT_87	[p5l897t3272r1387b3372],
66	of	IN	O	of	_	0	SENT_87	[p5l1422t3271r1523b3350],
67	speciﬁc	NN	O	speciﬁc	nn	68	SENT_87	[p5l1540t3271r1860b3372],
68	mutations	NNS	O	mutation	prep_of	65	SENT_87	[p5l1893t3288r2145b3351, p5l12t3400r216b3478],
69	within	IN	O	within	_	0	SENT_87	[p5l233t3399r504b3479],
70	the	DT	O	the	det	72	SENT_87	[p5l523t3400r650b3478],
71	kinase	NN	O	kinase	nn	72	SENT_87	[p5l669t3399r936b3479],
72	domain	NN	O	domain	prep_within	63	SENT_87	[p5l956t3400r1277b3478],
73	of	IN	O	of	_	0	SENT_87	[p5l1297t3399r1396b3478],
74	EGFR	NN	ORGANIZATION	egfr	prep_of	72	SENT_87	[p5l1396t3405r1665b3483],
75	.	.	O	.	_	0	SENT_87	[p5l1396t3405r1665b3483],

1	We	PRP	O	we	nsubj	4	SENT_88	[p5l1686t3407r1819b3478],
2	had	VBD	O	have	aux	4	SENT_88	[p5l1838t3400r1992b3478],
3	not	RB	O	not	neg	4	SENT_88	[p5l2011t3416r2153b3478],
4	detected	VBN	O	detect	_	0	SENT_88	[p5l12t3527r361b3606],
5	such	JJ	O	such	amod	6	SENT_88	[p5l383t3528r578b3607],
6	mutations	NNS	O	mutation	dobj	4	SENT_88	[p5l598t3528r1027b3607],
7	in	IN	O	in	_	0	SENT_88	[p5l1049t3528r1130b3605],
8	four	CD	NUMBER	four	num	12	SENT_88	[p5l1152t3527r1329b3607],
9	primary	JJ	O	primary	amod	12	SENT_88	[p5l1346t3528r1681b3628],
10	glioblasto	NN	O	glioblasto	nn	12	SENT_88	[p5l1697t3527r2146b3628],
11	—	NN	O	—	nn	12	SENT_88	[p5l1697t3527r2146b3628],
12	mas	NNS	O	ma	prep_in	4	SENT_88	[p5l12t3682r182b3734],
13	and	CC	O	and	_	0	SENT_88	[p5l206t3655r361b3734],
14	11	CD	NUMBER	11	num	19	SENT_88	[p5l387t3661r484b3733],
15	brain	NN	O	brain	nn	19	SENT_88	[p5l507t3656r1026b3735],
16	—	NN	O	—	nn	19	SENT_88	[p5l507t3656r1026b3735],
17	tumor	NN	O	tumor	nn	19	SENT_88	[p5l507t3656r1026b3735],
18	cell	NN	O	cell	nn	19	SENT_88	[p5l1047t3655r1187b3734],
19	lines	NNS	O	line	conj_and	12	SENT_88	[p5l1208t3656r1430b3751],
20	;	:	O	;	_	0	SENT_88	[p5l1208t3656r1430b3751],
21	the	DT	O	the	det	22	SENT_88	[p5l1457t3655r1585b3734],
22	fact	NN	O	fact	nsubj	49	SENT_88	[p5l1608t3655r1764b3734],
23	that	IN	O	that	complm	33	SENT_88	[p5l1781t3656r1947b3734],
24	nine	CD	NUMBER	nine	num	25	SENT_88	[p5l1964t3656r2147b3734],
25	glioblastomas	NNS	O	glioblastoma	nsubj	33	SENT_88	[p6l11t23r609b124],
26	that	WDT	O	that	nsubj	27	SENT_88	[p6l644t24r811b102],
27	exhibited	VBD	O	exhibit	rcmod	25	SENT_88	[p6l839t23r1230b102],
28	modest	JJ	O	modest	amod	29	SENT_88	[p6l1262t24r1581b102],
29	responses	NNS	O	response	dobj	27	SENT_88	[p6l1608t49r2031b124],
30	to	TO	O	to	_	0	SENT_88	[p6l2066t40r2145b102],
31	geﬁtinib	NN	O	geﬁtinib	prep_to	27	SENT_88	[p6l11t151r361b252],
32	also	RB	O	also	advmod	33	SENT_88	[p6l382t152r547b230],
33	lack	VBP	O	lack	dep	22	SENT_88	[p6l567t151r740b231],
34	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_88	[p6l753t158r964b231],
35	kinase	NN	O	kinase	nn	36	SENT_88	[p6l977t152r1244b231],
36	mutations	NNS	O	mutation	dobj	33	SENT_88	[p6l1265t152r1690b231],
37	and	CC	O	and	_	0	SENT_88	[p6l1712t152r1867b230],
38	do	VBP	O	do	aux	40	SENT_88	[p6l1887t152r1989b230],
39	not	RB	O	not	neg	40	SENT_88	[p6l2010t168r2153b230],
40	show	VB	O	show	conj_and	33	SENT_88	[p6l13t280r240b359],
41	consistent	JJ	O	consistent	amod	43	SENT_88	[p6l274t280r714b358],
42	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_88	[p6l744t286r958b359],
43	ampliﬁcation	NN	O	ampliﬁcation	dobj	40	SENT_88	[p6l987t279r1556b380],
44	or	CC	O	or	_	0	SENT_88	[p6l1594t305r1684b358],
45	vIII	NN	O	viii	nn	48	SENT_88	[p6l1713t287r1856b359],
46	muta	NN	O	muta	nn	48	SENT_88	[p6l1893t296r2145b359],
47	—	NN	O	—	nn	48	SENT_88	[p6l1893t296r2145b359],
48	tions	NNS	O	tion	dobj	40	SENT_88	[p6l12t408r220b486],
49	supports	VBZ	O	support	parataxis	4	SENT_88	[p6l255t424r624b508],
50	the	DT	O	the	det	53	SENT_88	[p6l658t408r788b486],
51	unique	JJ	O	unique	amod	53	SENT_88	[p6l818t408r1111b508],
52	drug	NN	O	drug	nn	53	SENT_88	[p6l1143t408r1343b508],
53	susceptibility	NN	O	susceptibility	nsubj	54	SENT_88	[p6l1372t408r1934b508],
54	conferred	VBD	O	confer	ccomp	49	SENT_88	[p6l1960t433r2145b486, p6l12t535r269b614],
55	by	IN	O	by	_	0	SENT_88	[p6l303t535r401b636],
56	the	DT	O	the	det	58	SENT_88	[p6l431t536r562b614],
57	kinase	NN	O	kinase	nn	58	SENT_88	[p6l596t535r873b615],
58	mutations	NNS	O	mutation	prep_by	54	SENT_88	[p6l907t536r1348b615],
59	we	PRP	O	we	nsubj	60	SENT_88	[p6l1379t562r1500b615],
60	described	VBD	O	describe	ccomp	54	SENT_88	[p6l1534t535r1975b614],
61	.	.	O	.	_	0	SENT_88	[p6l1534t535r1975b614],

1	We	PRP	O	we	nsubj	4	SENT_89	[p6l2010t543r2145b614],
2	can	MD	O	can	aux	4	SENT_89	[p6l12t680r312b742],
3	not	RB	O	not	neg	4	SENT_89	[p6l12t680r312b742],
4	comment	VB	O	comment	_	0	SENT_89	[p6l336t680r746b742],
5	on	IN	O	on	_	0	SENT_89	[p6l771t689r877b742],
6	unpublished	JJ	O	unpublished	amod	7	SENT_89	[p6l905t663r1440b764],
7	data	NNS	O	datum	prep_on	4	SENT_89	[p6l1469t664r1649b742],
8	about	IN	O	about	_	0	SENT_89	[p6l1675t663r1920b743],
9	cytoplasmic	JJ	O	cytoplasmic	prep_about	4	SENT_89	[p6l1944t680r2145b764, p6l11t792r343b892],
10	as	IN	O	as	dep	9	SENT_89	[p6l379t818r463b870],
11	compared	VBN	O	compare	_	0	SENT_89	[p6l502t792r928b892],
12	with	IN	O	with	prepc_compared_with	9	SENT_89	[p6l959t792r1150b871],
13	membranous	JJ	O	membranous	amod	14	SENT_89	[p6l1186t792r1752b871],
14	localization	NN	O	localization	pobj	9	SENT_89	[p6l1790t792r2145b870, p6l12t920r178b998],
15	of	IN	O	of	_	0	SENT_89	[p6l213t919r314b998],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_89	[p6l328t925r601b1003],
17	.	.	O	.	_	0	SENT_89	[p6l328t925r601b1003],

1	In	IN	O	in	_	0	SENT_90	[p6l640t927r727b997],
2	addition	NN	O	addition	_	0	SENT_90	[p6l760t919r1115b998],
3	to	TO	O	to	_	0	SENT_90	[p6l1149t936r1229b998],
4	altered	JJ	O	altered	amod	6	SENT_90	[p6l1263t919r1551b998],
5	receptor	NN	O	receptor	nn	6	SENT_90	[p6l1585t936r1938b1020],
6	processing	NN	O	processing	prep_in_addition_to	16	SENT_90	[p6l1967t945r2145b1020, p6l12t1048r349b1148],
7	,	,	O	,	_	0	SENT_90	[p6l1967t945r2145b1020, p6l12t1048r349b1148],
8	ampliﬁcation	NN	O	ampliﬁcation	prep_in_addition_to	16	SENT_90	[p6l383t1047r951b1148],
9	and	CC	O	and	_	0	SENT_90	[p6l979t1048r1135b1126],
10	overexpression	NN	O	overexpression	prep_in_addition_to	16	SENT_90	[p6l1165t1048r1802b1148],
11	of	IN	O	of	_	0	SENT_90	[p6l1831t1047r1932b1126],
12	EGFR	NN	ORGANIZATION	egfr	prep_of	6	SENT_90	[p6l1939t1054r2153b1127],
13	itself	PRP	O	itself	nsubj	16	SENT_90	[p6l11t1175r233b1254],
14	may	MD	O	may	aux	16	SENT_90	[p6l238t1202r414b1276],
15	well	RB	O	well	advmod	16	SENT_90	[p6l428t1175r602b1255],
16	result	VB	O	result	_	0	SENT_90	[p6l624t1175r864b1255],
17	in	IN	O	in	_	0	SENT_90	[p6l881t1176r963b1253],
18	stronger	JJR	O	stronger	amod	19	SENT_90	[p6l987t1192r1343b1276],
19	signals	NNS	O	signal	prep_in	16	SENT_90	[p6l1365t1176r1655b1276],
20	in	IN	O	in	prep	16	SENT_90	[p6l1681t1176r1761b1253],
21	both	CC	O	both	dep	20	SENT_90	[p6l1785t1175r1977b1254],
22	cellular	JJ	O	cellular	amod	23	SENT_90	[p6l2001t1175r2146b1254, p6l11t1304r205b1383],
23	compartments	NNS	O	compartment	conj	20	SENT_90	[p6l227t1320r871b1404],
24	.	.	O	.	_	0	SENT_90	[p6l227t1320r871b1404],

1	In	IN	O	in	_	0	SENT_91	[p6l140t1439r228b1509],
2	reply	NN	O	reply	prep_in	9	SENT_91	[p6l269t1432r480b1532],
3	to	TO	O	to	_	0	SENT_91	[p6l518t1448r597b1510],
4	Rossi	NNP	PERSON	Rossi	prep_to	2	SENT_91	[p6l639t1432r872b1515],
5	et	FW	O	et	nn	6	SENT_91	[p6l914t1448r991b1510],
6	al.	FW	O	al.	dep	4	SENT_91	[p6l1027t1431r1151b1527],
7	,	,	O	,	_	0	SENT_91	[p6l1027t1431r1151b1527],
8	we	PRP	O	we	nsubj	9	SENT_91	[p6l1194t1458r1313b1511],
9	note	VBP	O	note	_	0	SENT_91	[p6l1355t1448r1540b1510],
10	that	IN	O	that	complm	14	SENT_91	[p6l1583t1432r1751b1510],
11	previous	JJ	O	previous	amod	12	SENT_91	[p6l1786t1432r2145b1532],
12	studies	NNS	O	study	nsubj	14	SENT_91	[p6l13t1560r305b1639],
13	have	VBP	O	have	aux	14	SENT_91	[p6l330t1560r517b1639],
14	shown	VBN	O	show	ccomp	9	SENT_91	[p6l541t1560r820b1639],
15	no	DT	O	no	det	16	SENT_91	[p6l843t1585r949b1638],
16	correlation	NN	O	correlation	dobj	14	SENT_91	[p6l973t1560r1431b1638],
17	between	IN	O	between	_	0	SENT_91	[p6l1454t1560r1802b1639],
18	responsiveness	NN	O	responsiveness	prep_between	16	SENT_91	[p6l1825t1585r2146b1660, p6l13t1688r354b1767],
19	to	TO	O	to	_	0	SENT_91	[p6l378t1704r457b1766],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	14	SENT_91	[p6l479t1687r835b1788],
21	and	CC	O	and	_	0	SENT_91	[p6l857t1688r1014b1766],
22	levels	NNS	O	level	prep_to	14	SENT_91	[p6l1034t1687r1263b1767],
23	of	IN	O	of	_	0	SENT_91	[p6l1288t1687r1388b1766],
24	EGFR	NN	ORGANIZATION	egfr	nn	25	SENT_91	[p6l1390t1693r1650b1771],
25	expression	NN	O	expression	prep_of	20	SENT_91	[p6l1662t1688r2141b1788],
26	,	,	O	,	_	0	SENT_91	[p6l1662t1688r2141b1788],
27	as	IN	O	as	mark	42	SENT_91	[p6l11t1842r95b1894],
28	measured	VBN	O	measure	partmod	42	SENT_91	[p6l140t1816r555b1895],
29	by	IN	O	by	_	0	SENT_91	[p6l598t1816r695b1916],
30	immunohistochemical	JJ	O	immunohistochemical	amod	32	SENT_91	[p6l733t1815r1701b1895],
31	analysis	NN	O	analysis	nn	32	SENT_91	[p6l1742t1816r2144b1916],
32	.3	NN	NUMBER	.3	agent	28	SENT_91	[p6l1742t1816r2144b1916],
33	In	IN	O	in	_	0	SENT_91	[p6l10t1951r98b2021],
34	the	DT	O	the	det	35	SENT_91	[p6l128t1944r257b2022],
35	cases	NNS	O	case	prep_in	37	SENT_91	[p6l288t1970r506b2022],
36	we	PRP	O	we	nsubj	37	SENT_91	[p6l533t1970r653b2023],
37	studied	VBD	O	study	rcmod	32	SENT_91	[p6l684t1943r1016b2039],
38	,	,	O	,	_	0	SENT_91	[p6l684t1943r1016b2039],
39	we	PRP	O	we	nsubj	42	SENT_91	[p6l1047t1970r1166b2023],
40	did	VBD	O	do	aux	42	SENT_91	[p6l1197t1943r1330b2022],
41	not	RB	O	not	neg	42	SENT_91	[p6l1359t1960r1504b2022],
42	detect	VB	O	detect	advcl	14	SENT_91	[p6l1529t1943r1784b2022],
43	ampliﬁcation	NN	O	ampliﬁcation	dobj	42	SENT_91	[p6l1808t1943r2145b2044, p6l12t2072r271b2150],
44	of	IN	O	of	_	0	SENT_91	[p6l310t2071r411b2150],
45	either	CC	O	either	preconj	48	SENT_91	[p6l431t2072r675b2150],
46	wild	JJ	O	wild	amod	48	SENT_91	[p6l706t2071r1102b2172],
47	—	NN	O	—	nn	48	SENT_91	[p6l706t2071r1102b2172],
48	type	NN	O	type	prep_of	43	SENT_91	[p6l706t2071r1102b2172],
49	or	CC	O	or	_	0	SENT_91	[p6l1141t2097r1230b2150],
50	mutant	JJ	O	mutant	amod	52	SENT_91	[p6l1266t2088r1579b2151],
51	EGFR	NN	ORGANIZATION	egfr	nn	52	SENT_91	[p6l1610t2078r1824b2151],
52	alleles	NNS	O	allele	conj_or	48	SENT_91	[p6l1854t2071r2140b2150],
53	.	.	O	.	_	0	SENT_91	[p6l1854t2071r2140b2150],

1	As	IN	O	as	mark	2	SENT_92	[p6l8t2207r112b2278],
2	noted	VBN	O	note	advcl	13	SENT_92	[p6l149t2199r390b2278],
3	above	IN	O	above	prep	2	SENT_92	[p6l423t2200r689b2295],
4	,	,	O	,	_	0	SENT_92	[p6l423t2200r689b2295],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_92	[p6l727t2206r941b2279],
6	ampliﬁcation	NN	O	ampliﬁcation	nn	7	SENT_92	[p6l968t2199r1536b2300],
7	(	NN	O	(	nsubj	19	SENT_92	[p6l1575t2200r2020b2291],
8	measured	VBN	O	measure	partmod	7	SENT_92	[p6l1575t2200r2020b2291],
9	by	IN	O	by	_	0	SENT_92	[p6l2054t2200r2151b2300],
10	FISH	NN	O	fish	nn	11	SENT_92	[p6l10t2333r251b2419],
11	)	NN	O	)	agent	8	SENT_92	[p6l10t2333r251b2419],
12	is	VBZ	O	be	cop	13	SENT_92	[p6l277t2328r342b2406],
13	common	JJ	O	common	_	0	SENT_92	[p6l366t2353r745b2406],
14	in	IN	O	in	_	0	SENT_92	[p6l767t2328r847b2405],
15	glioblastomas	NNS	O	glioblastoma	prep_in	13	SENT_92	[p6l868t2328r1460b2428],
16	but	CC	O	but	_	0	SENT_92	[p6l1484t2327r1624b2407],
17	does	VBZ	O	do	aux	19	SENT_92	[p6l1642t2328r1833b2406],
18	not	RB	O	not	neg	19	SENT_92	[p6l1856t2344r1999b2406],
19	appear	VB	O	appear	conj_but	13	SENT_92	[p6l2015t2354r2146b2428, p6l11t2482r197b2556],
20	to	TO	O	to	aux	22	SENT_92	[p6l217t2472r296b2534],
21	be	VB	O	be	auxpass	22	SENT_92	[p6l321t2455r417b2534],
22	correlated	VBN	O	correlate	xcomp	19	SENT_92	[p6l440t2455r863b2534],
23	with	IN	O	with	_	0	SENT_92	[p6l881t2456r1071b2535],
24	geﬁtinib	NN	O	geﬁtinib	nn	25	SENT_92	[p6l1093t2455r1450b2556],
25	responsiveness	NN	O	responsiveness	prep_with	22	SENT_92	[p6l1475t2456r2141b2556],
26	.	.	O	.	_	0	SENT_92	[p6l1475t2456r2141b2556],

1	Again	RB	O	again	advmod	6	SENT_93	[p6l8t2584r278b2684],
2	,	,	O	,	_	0	SENT_93	[p6l8t2584r278b2684],
3	we	PRP	O	we	nsubj	6	SENT_93	[p6l300t2610r418b2663],
4	can	MD	O	can	aux	6	SENT_93	[p6l440t2600r729b2662],
5	not	RB	O	not	neg	6	SENT_93	[p6l440t2600r729b2662],
6	comment	VB	O	comment	_	0	SENT_93	[p6l745t2600r1150b2662],
7	on	IN	O	on	_	0	SENT_93	[p6l1166t2609r1272b2662],
8	unpublished	JJ	O	unpublished	amod	9	SENT_93	[p6l1292t2584r1819b2684],
9	data	NNS	O	datum	prep_on	6	SENT_93	[p6l1839t2584r2017b2662],
10	relating	VBG	O	relate	partmod	9	SENT_93	[p6l2036t2610r2146b2662, p6l11t2712r254b2812],
11	to	TO	O	to	_	0	SENT_93	[p6l280t2728r359b2790],
12	cellular	JJ	O	cellular	amod	14	SENT_93	[p6l389t2712r702b2791],
13	expression	NN	O	expression	nn	14	SENT_93	[p6l729t2712r1185b2812],
14	patterns	NNS	O	pattern	prep_to	10	SENT_93	[p6l1213t2728r1559b2812],
15	of	IN	O	of	_	0	SENT_93	[p6l1591t2711r1692b2790],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	14	SENT_93	[p6l1701t2717r1974b2807],
17	,	,	O	,	_	0	SENT_93	[p6l1701t2717r1974b2807],
18	but	CC	O	but	_	0	SENT_93	[p6l2010t2712r2152b2791],
19	we	PRP	O	we	nsubj	20	SENT_93	[p6l7t2866r126b2919],
20	note	VBP	O	note	conj_but	6	SENT_93	[p6l156t2856r340b2918],
21	that	IN	O	that	complm	24	SENT_93	[p6l370t2840r538b2918],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_93	[p6l559t2846r773b2919],
23	mutations	NNS	O	mutation	nsubj	24	SENT_93	[p6l795t2840r1229b2919],
24	are	VBP	O	be	ccomp	20	SENT_93	[p6l1259t2866r1386b2918],
25	within	IN	O	within	_	0	SENT_93	[p6l1410t2840r1686b2919],
26	the	DT	O	the	det	28	SENT_93	[p6l1716t2840r1846b2918],
27	kinase	NN	O	kinase	nn	28	SENT_93	[p6l1874t2840r2147b2919],
28	domain	NN	O	domain	prep_within	24	SENT_93	[p6l12t2967r361b3063],
29	,	,	O	,	_	0	SENT_93	[p6l12t2967r361b3063],
30	not	RB	O	not	neg	28	SENT_93	[p6l388t2984r532b3046],
31	the	DT	O	the	det	33	SENT_93	[p6l549t2968r679b3046],
32	juxtamembrane	NN	O	juxtamembrane	nn	33	SENT_93	[p6l687t2968r1370b3068],
33	domain	NN	O	domain	dep	28	SENT_93	[p6l1392t2968r1741b3046],
34	.	.	O	.	_	0	SENT_93	[p6l1392t2968r1741b3046],

1	We	PRP	O	we	nsubj	2	SENT_94	[p6l1764t2975r1898b3046],
2	agree	VBP	O	agree	_	0	SENT_94	[p6l1919t2994r2147b3068],
3	that	IN	O	that	complm	11	SENT_94	[p6l12t3096r180b3174],
4	the	DT	O	the	det	5	SENT_94	[p6l197t3096r326b3174],
5	effectiveness	NN	O	effectiveness	nsubj	11	SENT_94	[p6l349t3095r885b3175],
6	of	IN	O	of	_	0	SENT_94	[p6l910t3095r1011b3174],
7	antibodies	NNS	O	antibody	prep_of	5	SENT_94	[p6l1014t3096r1456b3174],
8	directed	VBN	O	direct	partmod	7	SENT_94	[p6l1480t3095r1820b3174],
9	against	IN	O	against	_	0	SENT_94	[p6l1842t3096r2152b3196],
10	EGFR	NN	ORGANIZATION	egfr	prep_against	8	SENT_94	[p6l10t3229r271b3307],
11	needs	VBZ	O	need	ccomp	2	SENT_94	[p6l295t3224r537b3302],
12	to	TO	O	to	aux	14	SENT_94	[p6l575t3240r654b3302],
13	be	VB	O	be	auxpass	14	SENT_94	[p6l690t3224r786b3302],
14	evaluated	VBN	O	evaluate	xcomp	11	SENT_94	[p6l822t3224r1217b3303],
15	in	IN	O	in	_	0	SENT_94	[p6l1250t3224r1332b3301],
16	mutation	NN	O	mutation	prep_in	14	SENT_94	[p6l1367t3224r2147b3324],
17	—	CD	NUMBER	—	num	19	SENT_94	[p6l1367t3224r2147b3324],
18	negative	JJ	O	negative	amod	19	SENT_94	[p6l1367t3224r2147b3324],
19	cases	NNS	O	case	dep	16	SENT_94	[p6l12t3350r256b3402],
20	.	.	O	.	_	0	SENT_94	[p6l12t3350r256b3402],

1	Daniel	NNP	PERSON	Daniel	nn	3	SENT_95	[p6l20t3484r290b3565],
2	A.	NNP	PERSON	A.	nn	3	SENT_95	[p6l325t3489r408b3565],
3	Haber	NNP	PERSON	Haber	_	0	SENT_95	[p6l452t3484r729b3579],
4	,	,	O	,	_	0	SENT_95	[p6l452t3484r729b3579],
5	M.D.	NNP	O	M.D.	nn	7	SENT_95	[p6l775t3492r1008b3579],
6	,	,	O	,	_	0	SENT_95	[p6l775t3492r1008b3579],
7	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_95	[p6l1053t3484r1283b3565],
8	.	.	O	.	_	0	SENT_95	[p6l1053t3484r1283b3565],

1	Daphne	NNP	PERSON	Daphne	nn	3	SENT_96	[p6l20t3613r359b3718],
2	W.	NNP	PERSON	W.	nn	3	SENT_96	[p6l389t3621r489b3693],
3	Bell	NNP	PERSON	Bell	_	0	SENT_96	[p6l533t3613r707b3708],
4	,	,	O	,	_	0	SENT_96	[p6l533t3613r707b3708],
5	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_96	[p6l752t3613r982b3693],
6	.	.	O	.	_	0	SENT_96	[p6l752t3613r982b3693],

1	Thomas	NNP	PERSON	Thomas	nn	2	SENT_97	[p7l9t18r451b121],
2	]	NNP	O	]	_	0	SENT_97	[p7l9t18r451b121],
3	.	.	O	.	_	0	SENT_97	[p7l9t18r451b121],

1	Lynch	NNP	PERSON	Lynch	_	0	SENT_98	[p7l495t18r760b124],
2	,	,	O	,	_	0	SENT_98	[p7l495t18r760b124],
3	M.D.	NNP	O	M.D.	appos	1	SENT_98	[p7l805t26r1012b98],

1	Massachusetts	NNP	LOCATION	Massachusetts	nn	5	SENT_99	[p7l17t171r509b232],
2	General	NNP	O	General	nn	5	SENT_99	[p7l536t171r789b232],
3	Hospital	NNP	O	Hospital	nn	5	SENT_99	[p7l822t171r1096b250],
4	Cancer	NNP	O	Cancer	nn	5	SENT_99	[p7l1126t175r1352b232],
5	Center	NNP	O	Center	_	0	SENT_99	[p7l1375t175r1590b232],

1	Boston	NNP	LOCATION	Boston	nn	3	SENT_100	[p7l17t288r263b354],
2	,	,	O	,	_	0	SENT_100	[p7l17t288r263b354],
3	MA	NNP	O	MA	_	0	SENT_100	[p7l296t287r406b343],
4	02115	CD	DATE	02115	num	3	SENT_100	[p7l428t287r622b344],
5	haber@he	JJ	O	haber@he	amod	7	SENT_100	[p7l14t370r1022b450],
6	|	NN	O	|	nn	7	SENT_100	[p7l14t370r1022b450],
7	ix.mgh.harvard.edu	NN	O	ix.mgh.harvard.edu	dep	3	SENT_100	[p7l14t370r1022b450],
8	1	CD	NUMBER	1	dep	7	SENT_100	[p7l13t482r62b534],
9	.	.	O	.	_	0	SENT_100	[p7l13t482r62b534],

1	Frederick	NNP	PERSON	Frederick	nn	2	SENT_101	[p7l139t475r443b535],
2	L	NNP	PERSON	L	_	0	SENT_101	[p7l456t480r511b547],
3	,	,	O	,	_	0	SENT_101	[p7l456t480r511b547],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_101	[p7l529t480r718b551],
5	X	NNP	O	X	appos	2	SENT_101	[p7l729t480r847b547],
6	.	.	O	.	_	0	SENT_101	[p7l729t480r847b547],

1	—	NN	O	—	_	0	SENT_102	[p7l729t480r847b547],
2	.	.	O	.	_	0	SENT_102	[p7l729t480r847b547],

1	Y	NN	O	y	_	0	SENT_103	[p7l729t480r847b547],
2	,	,	O	,	_	0	SENT_103	[p7l729t480r847b547],
3	Eley	NNP	PERSON	Eley	nn	4	SENT_103	[p7l868t475r1000b551],
4	G	NNP	O	G	appos	1	SENT_103	[p7l1014t479r1085b547],
5	,	,	O	,	_	0	SENT_103	[p7l1014t479r1085b547],
6	James	NNP	PERSON	James	nn	7	SENT_103	[p7l1099t480r1293b544],
7	CD	NNP	O	CD	appos	4	SENT_103	[p7l1312t479r1427b534],
8	.	.	O	.	_	0	SENT_103	[p7l1312t479r1427b534],

1	Diversity	NN	O	diversity	_	0	SENT_104	[p7l1447t475r1728b551],
2	and	CC	O	and	_	0	SENT_104	[p7l1742t475r1859b534],
3	frequency	NN	O	frequency	conj_and	1	SENT_104	[p7l1876t474r2147b551, p7l11t581r77b637],
4	of	IN	O	of	_	0	SENT_104	[p7l103t560r178b620],
5	epidermal	JJ	O	epidermal	amod	9	SENT_104	[p7l194t561r514b637],
6	growth	NN	O	growth	nn	9	SENT_104	[p7l542t561r771b637],
7	factor	NN	O	factor	nn	9	SENT_104	[p7l800t560r986b620],
8	receptor	NN	O	receptor	nn	9	SENT_104	[p7l1012t573r1277b637],
9	mutations	NNS	O	mutation	prep_of	1	SENT_104	[p7l1303t561r1627b621],
10	in	IN	O	in	_	0	SENT_104	[p7l1657t561r1718b619],
11	human	JJ	O	human	amod	14	SENT_104	[p7l1747t561r1973b621],
12	glio	NN	O	glio	nn	14	SENT_104	[p7l2001t561r2147b637],
13	—	NN	O	—	nn	14	SENT_104	[p7l2001t561r2147b637],
14	blastomas	NNS	O	blastoma	prep_in	9	SENT_104	[p7l11t643r355b701],
15	.	.	O	.	_	0	SENT_104	[p7l11t643r355b701],

1	Cancer	NNP	O	Cancer	nn	2	SENT_105	[p7l378t647r601b701],
2	Res	NNP	O	Res	_	0	SENT_105	[p7l616t647r729b705],
3	2000	CD	DATE	2000	num	2	SENT_105	[p7l750t647r1273b714],
4	;	:	O	;	_	0	SENT_105	[p7l750t647r1273b714],
5	60:1383	CD	NUMBER	60:1383	num	6	SENT_105	[p7l750t647r1273b714],
6	—	NN	O	—	dep	2	SENT_105	[p7l750t647r1273b714],
7	7	CD	NUMBER	7	dep	6	SENT_105	[p7l750t647r1273b714],
8	.	.	O	.	_	0	SENT_105	[p7l750t647r1273b714],

1	2	LS	NUMBER	2	_	0	SENT_106	[p7l9t735r62b787],
2	.	.	O	.	_	0	SENT_106	[p7l9t735r62b787],

1	Rich	NNP	O	Rich	nn	2	SENT_107	[p7l139t728r285b791],
2	JN	NN	O	jn	_	0	SENT_107	[p7l298t733r397b800],
3	,	,	O	,	_	0	SENT_107	[p7l298t733r397b800],
4	Reardon	NNP	ORGANIZATION	Reardon	nn	5	SENT_107	[p7l422t728r693b791],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_107	[p7l714t733r830b800],
6	,	,	O	,	_	0	SENT_107	[p7l714t733r830b800],
7	Peery	NNP	PERSON	Peery	nn	8	SENT_107	[p7l855t733r1026b804],
8	T	NN	O	t	appos	2	SENT_107	[p7l1041t732r1097b800],
9	,	,	O	,	_	0	SENT_107	[p7l1041t732r1097b800],
10	et	FW	O	et	nn	11	SENT_107	[p7l1123t740r1181b787],
11	al.	FW	O	al.	appos	2	SENT_107	[p7l1197t728r1269b787],
12	.	.	O	.	_	0	SENT_107	[p7l1197t728r1269b787],

1	Phase	NN	O	phase	nn	3	SENT_108	[p7l1293t728r1478b787],
2	II	CD	NUMBER	ii	num	3	SENT_108	[p7l1498t733r1546b786],
3	trial	NN	O	trial	_	0	SENT_108	[p7l1567t728r1693b787],
4	of	IN	O	of	_	0	SENT_108	[p7l1714t727r1790b787],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_108	[p7l1797t727r2065b804],
6	in	IN	O	in	_	0	SENT_108	[p7l2087t728r2148b786],
7	recurrent	JJ	O	recurrent	amod	8	SENT_108	[p7l11t823r307b870],
8	glioblastoma	NN	O	glioblastoma	prep_in	3	SENT_108	[p7l322t811r757b886],
9	.	.	O	.	_	0	SENT_108	[p7l322t811r757b886],

1	J	NNP	O	J	nn	3	SENT_109	[p7l772t816r801b879],
2	Clin	NNP	O	Clin	nn	3	SENT_109	[p7l817t811r949b869],
3	Oncol	NNP	O	Oncol	_	0	SENT_109	[p7l968t811r1159b869],
4	2004	CD	DATE	2004	num	3	SENT_109	[p7l1178t815r1701b882],
5	;	:	O	;	_	0	SENT_109	[p7l1178t815r1701b882],
6	22:133	CD	NUMBER	22:133	number	7	SENT_109	[p7l1178t815r1701b882],
7	—	CD	NUMBER	—	dep	3	SENT_109	[p7l1178t815r1701b882],
8	42	CD	NUMBER	42	dep	7	SENT_109	[p7l1178t815r1701b882],
9	.	.	O	.	_	0	SENT_109	[p7l1178t815r1701b882],

1	3	LS	NUMBER	3	_	0	SENT_110	[p7l11t901r62b953],
2	.	.	O	.	_	0	SENT_110	[p7l11t901r62b953],

1	Wakeling	VBG	PERSON	wakele	_	0	SENT_111	[p7l138t895r443b970],
2	AE	NN	O	ae	dobj	1	SENT_111	[p7l461t900r570b966],
3	,	,	O	,	_	0	SENT_111	[p7l461t900r570b966],
4	Guy	NNP	O	Guy	nn	5	SENT_111	[p7l597t899r728b970],
5	SP	NN	O	sp	appos	2	SENT_111	[p7l749t899r833b966],
6	,	,	O	,	_	0	SENT_111	[p7l749t899r833b966],
7	Woodburn	NNP	ORGANIZATION	Woodburn	nn	8	SENT_111	[p7l857t895r1203b954],
8	JR	NNP	ORGANIZATION	JR	appos	2	SENT_111	[p7l1218t899r1312b966],
9	,	,	O	,	_	0	SENT_111	[p7l1218t899r1312b966],
10	et	FW	O	et	nn	11	SENT_111	[p7l1339t907r1397b953],
11	al.	FW	O	al.	appos	2	SENT_111	[p7l1415t895r1487b953],
12	.	.	O	.	_	0	SENT_111	[p7l1415t895r1487b953],

1	ZD1839	NN	O	zd1839	_	0	SENT_112	[p7l1512t899r1767b954],
2	(	CD	NUMBER	(	num	1	SENT_112	[p7l1794t900r2047b963],
3	Iressa	NNP	O	Iressa	dep	1	SENT_112	[p7l1794t900r2047b963],
4	)	CD	NUMBER	)	num	3	SENT_112	[p7l1794t900r2047b963],
5	:	:	O	:	_	0	SENT_112	[p7l1794t900r2047b963],
6	an	DT	O	a	det	9	SENT_112	[p7l2072t914r2148b953],
7	orally	RB	O	orally	advmod	8	SENT_112	[p7l11t981r190b1057],
8	active	JJ	O	active	amod	9	SENT_112	[p7l204t981r382b1041],
9	inhibitor	NN	O	inhibitor	dep	1	SENT_112	[p7l400t981r684b1040],
10	of	IN	O	of	_	0	SENT_112	[p7l701t980r776b1040],
11	epidermal	JJ	O	epidermal	amod	14	SENT_112	[p7l781t981r1103b1057],
12	growth	NN	O	growth	nn	14	SENT_112	[p7l1121t981r1349b1057],
13	factor	NN	O	factor	nn	14	SENT_112	[p7l1368t980r1554b1040],
14	signaling	NN	O	signaling	prep_of	9	SENT_112	[p7l1571t981r1869b1057],
15	with	IN	O	with	_	0	SENT_112	[p7l1882t981r2025b1041],
16	potential	JJ	O	potential	prep_with	14	SENT_112	[p7l2042t1000r2148b1057, p7l11t1065r210b1124],
17	for	IN	O	for	_	0	SENT_112	[p7l229t1064r321b1124],
18	cancer	NN	O	cancer	nn	19	SENT_112	[p7l339t1084r546b1124],
19	therapy	NN	O	therapy	prep_for	16	SENT_112	[p7l563t1065r810b1141],
20	.	.	O	.	_	0	SENT_112	[p7l563t1065r810b1141],

1	Cancer	NNP	O	Cancer	nn	2	SENT_113	[p7l833t1069r1056b1124],
2	Res	NNP	O	Res	_	0	SENT_113	[p7l1072t1070r1185b1128],
3	2002	CD	DATE	2002	num	2	SENT_113	[p7l1205t1069r1768b1137],
4	;	:	O	;	_	0	SENT_113	[p7l1205t1069r1768b1137],
5	62:5749	CD	NUMBER	62:5749	number	6	SENT_113	[p7l1205t1069r1768b1137],
6	—	CD	NUMBER	—	dep	2	SENT_113	[p7l1205t1069r1768b1137],
7	54	CD	NUMBER	54	dep	6	SENT_113	[p7l1205t1069r1768b1137],
8	.	.	O	.	_	0	SENT_113	[p7l1205t1069r1768b1137],

1	JM	NN	O	jm	_	0	SENT_114	[p7l578t1222r618b1243],
2	0351	CD	DATE	0351	num	1	SENT_114	[p7l640t1221r712b1243],
3	,	,	O	,	_	0	SENT_114	[p7l640t1221r712b1243],
4	2	CD	NUMBER	2	num	5	SENT_114	[p7l729t1221r742b1237],
5	www	NN	O	www	appos	1	SENT_114	[p7l777t1222r851b1237],
6	.	.	O	.	_	0	SENT_114	[p7l777t1222r851b1237],

1	J	NN	O	j	_	0	SENT_115	[p7l889t1222r897b1243],
2	.	.	O	.	_	0	SENT_115	[p7l928t1233r931b1237],

1	EPTEMBER16	NN	O	eptember16	_	0	SENT_116	[p7l1042t1216r1300b1243],
2	,2004	CD	NUMBER	,2004	num	3	SENT_116	[p7l1042t1216r1300b1243],
3	1261	CD	DATE	1261	dep	1	SENT_116	[p7l1940t1219r2016b1241],

1	The	DT	O	the	det	4	SENT_117	[p7l702t1254r753b1277],
2	New	NNP	O	New	nn	4	SENT_117	[p7l762t1255r824b1277],
3	England	NNP	O	England	nn	4	SENT_117	[p7l833t1254r944b1284],
4	Journal	NNP	O	Journal	_	0	SENT_117	[p7l952t1254r1050b1277],
5	of	IN	O	of	_	0	SENT_117	[p7l1060t1254r1088b1277],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_117	[p7l1095t1254r1220b1277],

1	Downloaded	VBN	O	download	_	0	SENT_118	[p7l144t1294r314b1317],
2	from	IN	O	from	_	0	SENT_118	[p7l323t1294r387b1317],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_118	[p7l396t1294r514b1324],
4	at	IN	O	at	_	0	SENT_118	[p7l524t1298r547b1317],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_118	[p7l556t1294r739b1317],
6	on	IN	O	on	_	0	SENT_118	[p7l748t1301r780b1317],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_118	[p7l789t1294r849b1317],
8	5	CD	DATE	5	num	7	SENT_118	[p7l902t1294r924b1321],
9	,	,	DATE	,	_	0	SENT_118	[p7l902t1294r924b1321],
10	2014	CD	DATE	2014	num	7	SENT_118	[p7l935t1294r1007b1317],
11	.	.	O	.	_	0	SENT_118	[p7l935t1294r1007b1317],

1	For	IN	O	for	_	0	SENT_119	[p7l1018t1294r1064b1317],
2	personal	JJ	O	personal	amod	3	SENT_119	[p7l1072t1294r1184b1324],
3	use	NN	O	use	pobj	1	SENT_119	[p7l1194t1301r1237b1317],
4	only	RB	O	only	advmod	3	SENT_119	[p7l1247t1294r1311b1324],
5	.	.	O	.	_	0	SENT_119	[p7l1247t1294r1311b1324],

1	No	DT	O	no	det	3	SENT_120	[p7l1322t1294r1362b1317],
2	other	JJ	O	other	amod	3	SENT_120	[p7l1372t1294r1440b1317],
3	uses	NNS	O	use	_	0	SENT_120	[p7l1448t1301r1504b1317],
4	without	IN	O	without	_	0	SENT_120	[p7l1514t1294r1615b1317],
5	permission	NN	O	permission	prep_without	3	SENT_120	[p7l1624t1294r1776b1324],
6	.	.	O	.	_	0	SENT_120	[p7l1624t1294r1776b1324],

1	Copyright	NN	O	copyright	nn	5	SENT_121	[p7l494t1335r629b1365],
2	©	CD	NUMBER	©	num	5	SENT_121	[p7l638t1335r661b1358],
3	2004	CD	DATE	2004	num	5	SENT_121	[p7l672t1335r737b1358],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_121	[p7l746t1336r844b1358],
5	usetts	NNP	O	usetts	_	0	SENT_121	[p7l863t1339r937b1358],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_121	[p7l947t1335r1055b1358],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_121	[p7l1065t1335r1170b1365],
8	.	.	O	.	_	0	SENT_121	[p7l1065t1335r1170b1365],

1	All	DT	O	all	det	2	SENT_122	[p7l1181t1335r1223b1358],
2	rights	NNS	O	rights	nsubj	3	SENT_122	[p7l1232t1335r1306b1365],
3	reserved	VBN	O	reserve	_	0	SENT_122	[p7l1316t1335r1435b1358],
4	.	.	O	.	_	0	SENT_122	[p7l1316t1335r1435b1358],

